{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:36:49Z","timestamp":1780439809172,"version":"3.54.1"},"reference-count":252,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Schleswig-Holstein - Campus Kiel"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol. Res. Pract."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Parkinson\u2019s disease (PD) is the fastest growing neurological disorder worldwide and, together with other movement disorders, belongs to a group of chronic neurological conditions associated with a substantial burden for affected individuals, caregivers, and healthcare systems. Despite significant advances in symptomatic treatment, disease-modifying therapies remain unavailable, shifting increasing attention toward prevention as a key therapeutic strategy. In this narrative we primarily focus on PD, as the epidemiologically most challenging condition and the one for which the most comprehensive evidence base for preventive strategies has been established. Preventive approaches relevant to other movement disorders are briefly discussed to highlight other promising targets requiring further investigations. In recent years major progress has been achieved in the identification of modifiable factors relevant for primary prevention of PD. Well-supported factors include physical activity, adherence to a Mediterranean diet, and caffeine or tea consumption as protective factors, as well as pesticide exposure as a relevant risk factor. Advances in early and prodromal diagnosis of PD have opened new perspectives for secondary prevention. Earlier identification of individuals at risk may enable timely interventions aimed at attenuating early disease progression. However, despite this progress, the systematic implementation of early therapeutic interventions in the prodromal phase remains limited. Evidence is sparse and largely indirect, mainly inferred from later disease onset associated with physical activity and dietary patterns. Similarly, although early diagnosis and treatment of cognitive impairment are clearly recommended by clinical guidelines, they remain insufficiently integrated into routine clinical care. Finally, tertiary prevention strategies are supported by a broad evidence base. Multidisciplinary rehabilitative care models have demonstrated clear benefits in preventing complications, maintaining daily functioning and quality of life. While such rehabilitative approaches are widely implemented, the strong evidence supporting moderate- to high-intensity physical exercise remains insufficiently translated into routine practice. Looking ahead, a key goal for the coming decades is the development of personalized prevention strategies, including beyond other insights into gene-environment interactions and the integration of multi-omics data to tailor interventions to individual risk profiles. Such approaches hold promise to maximize preventive efficacy and reduce the overall burden of PD and related movement disorders.<\/jats:p>","DOI":"10.1186\/s42466-026-00488-2","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:23:03Z","timestamp":1776698583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Preventing Parkinson\u2019s disease in the context of movement disorders: a narrative review of current evidence and future directions"],"prefix":"10.1186","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0792-4383","authenticated-orcid":false,"given":"Eva","family":"Schaeffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos Steffen","family":"Becktepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Brockmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Eggers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"G\u00fclke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Kalbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim W.","family":"Rattay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"T\u00f6nges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Warnecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten E.","family":"Zeuner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"issue":"4","key":"488_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000524208","volume":"56","author":"Q-Q Zhong","year":"2022","unstructured":"Zhong, Q.-Q., & Zhu, F. (2022). Trends in prevalence cases and disability-adjusted life-years of Parkinson\u2019s disease: Findings from the Global Burden of Disease Study 2019. Neuroepidemiology, 56(4), 261\u2013270. https:\/\/doi.org\/10.1159\/000524208","journal-title":"Neuroepidemiology"},{"issue":"4","key":"488_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"GBD 2021 Nervous System Disorders Collaborators","year":"2024","unstructured":"GBD 2021 Nervous System Disorders Collaborators. (2024). Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021. The Lancet. Neurology, 23(4), 344\u2013381. https:\/\/doi.org\/10.1016\/S1474-4422(24)00038-3","journal-title":"The Lancet. Neurology"},{"issue":"11","key":"488_CR3","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1002\/mds.29995","volume":"39","author":"A Wijers","year":"2024","unstructured":"Wijers, A., Ravi, A., Evers, S. M. A. A., Tissingh, G., & van Mastrigt, G. A. P. G. (2024). Systematic review of the cost of illness of Parkinson\u2019s disease from a societal perspective. Movement Disorders\u202f: Official Journal of the Movement Disorder Society, 39(11), 1938\u20131951. https:\/\/doi.org\/10.1002\/mds.29995","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"issue":"9","key":"488_CR4","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1001\/jamaneurol.2022.1783","volume":"79","author":"N Schiess","year":"2022","unstructured":"Schiess, N., Cataldi, R., Okun, M. S., Fothergill-Misbah, N., Dorsey, E. R., Bloem, B. R., Barretto, M., Bhidayasiri, R., Brown, R., Chishimba, L., Chowdhary, N., Coslov, M., Cubo, E., Di Rocco, A., Dolhun, R., Dowrick, C., Fung, V. S. C., Gershanik, O. S., Gifford, L., & Dua, T. (2022). Six action steps to address global disparities in Parkinson disease: A World Health Organization priority. JAMA Neurology, 79(9), 929\u2013936. https:\/\/doi.org\/10.1001\/jamaneurol.2022.1783","journal-title":"JAMA Neurology"},{"key":"488_CR5","unstructured":"Parkinson disease: A public health approach: technical brief. (n.d.). Retrieved July 31, (2024). from https:\/\/www.who.int\/publications\/i\/item\/9789240050983"},{"issue":"12","key":"488_CR6","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg, D., Postuma, R. B., Adler, C. H., Bloem, B. R., Chan, P., Dubois, B., Gasser, T., Goetz, C. G., Halliday, G., Joseph, L., Lang, A. E., Liepelt-Scarfone, I., Litvan, I., Marek, K., Obeso, J., Oertel, W., Olanow, C. W., Poewe, W., Stern, M., & Deuschl, G. (2015). MDS research criteria for prodromal Parkinson\u2019s disease: MDS criteria for prodromal PD. Movement Disorders, 30(12), 1600\u20131611. https:\/\/doi.org\/10.1002\/mds.26431","journal-title":"Movement Disorders"},{"key":"488_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27802","author":"S Heinzel","year":"2019","unstructured":"Heinzel, S., Berg, D., Gasser, T., Chen, H., Yao, C., Postuma, R. B., MDS Task Force on the Definition of Parkinson\u2019s Disease. (2019). Update of the MDS research criteria for prodromal Parkinson\u2019s disease. Movement Disorders. https:\/\/doi.org\/10.1002\/mds.27802","journal-title":"Movement Disorders"},{"issue":"1","key":"488_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00724-z","volume":"10","author":"H Nishiwaki","year":"2024","unstructured":"Nishiwaki, H., Ueyama, J., Ito, M., Hamaguchi, T., Takimoto, K., Maeda, T., Kashihara, K., Tsuboi, Y., Mori, H., Kurokawa, K., Katsuno, M., Hirayama, M., & Ohno, K. (2024). Meta-analysis of shotgun sequencing of gut microbiota in Parkinson\u2019s disease. NPJ Parkinson\u2019s Disease, 10(1), Article 106. https:\/\/doi.org\/10.1038\/s41531-024-00724-z","journal-title":"NPJ Parkinson's Disease"},{"issue":"7","key":"488_CR9","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3233\/JPD-230206","volume":"13","author":"K Kulcsarova","year":"2023","unstructured":"Kulcsarova, K., Bang, C., Berg, D., & Schaeffer, E. (2023). Pesticides and the microbiome-gut-brain axis: Convergent pathways in the pathogenesis of Parkinson\u2019s disease. Journal of Parkinson\u2019s Disease, 13(7), 1079\u20131106. https:\/\/doi.org\/10.3233\/JPD-230206","journal-title":"Journal of Parkinson's Disease"},{"issue":"4","key":"488_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1212\/WNL.0b013e3181ea1597","volume":"75","author":"Q Xu","year":"2010","unstructured":"Xu, Q., Park, Y., Huang, X., Hollenbeck, A., Blair, A., Schatzkin, A., & Chen, H. (2010). Physical activities and future risk of Parkinson disease. Neurology, 75(4), 341\u2013348. https:\/\/doi.org\/10.1212\/WNL.0b013e3181ea1597","journal-title":"Neurology"},{"issue":"4","key":"488_CR11","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1212\/01.WNL.0000151960.28687.93","volume":"64","author":"H Chen","year":"2005","unstructured":"Chen, H., Zhang, S. M., Schwarzschild, M. A., Hern\u00e1n, M. A., & Ascherio, A. (2005). Physical activity and the risk of Parkinson disease. Neurology, 64(4), 664\u2013669. https:\/\/doi.org\/10.1212\/01.WNL.0000151960.28687.93","journal-title":"Neurology"},{"issue":"Pt 2","key":"488_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/brain\/awu323","volume":"138","author":"F Yang","year":"2015","unstructured":"Yang, F., Trolle Lagerros, Y., Bellocco, R., Adami, H.-O., Fang, F., Pedersen, N. L., & Wirdefeldt, K. (2015). Physical activity and risk of Parkinson\u2019s disease in the Swedish National March Cohort. Brain\u202f: A Journal of Neurology, 138(Pt 2), 269\u2013275. https:\/\/doi.org\/10.1093\/brain\/awu323","journal-title":"Brain : A Journal of Neurology"},{"issue":"5","key":"488_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.2421","volume":"1","author":"X Fang","year":"2018","unstructured":"Fang, X., Han, D., Cheng, Q., Zhang, P., Zhao, C., Min, J., & Wang, F. (2018). Association of levels of physical activity with risk of Parkinson disease: A systematic review and meta-analysis. JAMA Network Open, 1(5), Article e182421. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.2421","journal-title":"JAMA Network Open"},{"issue":"3","key":"488_CR14","doi-asserted-by":"publisher","first-page":"919","DOI":"10.3233\/JPD-202521","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen, Y., Sun, X., Lin, Y., Zhang, Z., Gao, Y., & Wu, I. X. Y. (2021). Non-genetic risk factors for Parkinson\u2019s disease: An overview of 46 systematic reviews. Journal of Parkinson\u2019s Disease, 11(3), 919\u2013935. https:\/\/doi.org\/10.3233\/JPD-202521","journal-title":"Journal of Parkinson's Disease"},{"issue":"10484","key":"488_CR15","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0140-6736(25)00184-9","volume":"405","author":"AR Tari","year":"2025","unstructured":"Tari, A. R., Walker, T. L., Huuha, A. M., Sando, S. B., & Wisloff, U. (2025). Neuroprotective mechanisms of exercise and the importance of fitness for healthy brain ageing. Lancet, 405(10484), 1093\u20131118. https:\/\/doi.org\/10.1016\/S0140-6736(25)00184-9","journal-title":"Lancet"},{"issue":"12","key":"488_CR16","doi-asserted-by":"publisher","first-page":"7434","DOI":"10.1007\/s00415-024-12672-y","volume":"271","author":"Y Jiang","year":"2024","unstructured":"Jiang, Y., Zhang, S., Chen, Y., Wang, H., He, X., Bin, C., Fu, R., Wang, H., Zhu, H., Pan, M., Zhang, Q., & Lu, Y. (2024). Physical activity and risk of Parkinson\u2019s disease: An updated systematic review and meta-analysis. Journal of Neurology, 271(12), 7434\u20137459. https:\/\/doi.org\/10.1007\/s00415-024-12672-y","journal-title":"Journal of Neurology"},{"issue":"1","key":"488_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/mds.28314","volume":"36","author":"W Yin","year":"2021","unstructured":"Yin, W., L\u00f6f, M., Pedersen, N. L., Sandin, S., & Fang, F. (2021). Mediterranean dietary pattern at middle age and risk of Parkinson\u2019s disease: A Swedish cohort study. Movement Disorders\u202f: Official Journal of the Movement Disorder Society, 36(1), 255\u2013260. https:\/\/doi.org\/10.1002\/mds.28314","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"issue":"10","key":"488_CR18","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s12603-018-1094-5","volume":"22","author":"P Agarwal","year":"2018","unstructured":"Agarwal, P., Wang, Y., Buchman, A. S., Holland, T. M., Bennett, D. A., & Morris, M. C. (2018). MIND diet associated with reduced incidence and delayed progression of ParkinsonismA in old age. The Journal of Nutrition, Health & Aging, 22(10), 1211\u20131215. https:\/\/doi.org\/10.1007\/s12603-018-1094-5","journal-title":"The Journal of Nutrition, Health & Aging"},{"issue":"6","key":"488_CR19","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/mds.24918","volume":"27","author":"RN Alcalay","year":"2012","unstructured":"Alcalay, R. N., Gu, Y., Mejia-Santana, H., Cote, L., Marder, K. S., & Scarmeas, N. (2012). The association between Mediterranean diet adherence and Parkinson\u2019s disease. Movement Disorders, 27(6), 771\u2013774. https:\/\/doi.org\/10.1002\/mds.24918","journal-title":"Movement Disorders"},{"key":"488_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1600955","volume":"12","author":"R Zhang","year":"2025","unstructured":"Zhang, R., Shu, L., Zhu, Q., & Li, N. (2025). Adherence to a priori and a posteriori dietary patterns and risk of Parkinson\u2019s disease: A systematic review and meta-analysis of observational studies. Frontiers in Nutrition, 12, Article 1600955. https:\/\/doi.org\/10.3389\/fnut.2025.1600955","journal-title":"Frontiers in Nutrition"},{"issue":"5","key":"488_CR21","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jand.2022.12.005","volume":"123","author":"M Bonaccio","year":"2023","unstructured":"Bonaccio, M., Costanzo, S., Di Castelnuovo, A., Gialluisi, A., Ruggiero, E., De Curtis, A., Persichillo, M., Cerletti, C., Donati, M. B., de Gaetano, G., & Iacoviello, L. (2023). Increased adherence to a Mediterranean diet is associated with reduced low-grade inflammation after a 12.7-year period: Results from the Moli-sani Study. Journal of the Academy of Nutrition and Dietetics, 123(5), 783-795.e7. https:\/\/doi.org\/10.1016\/j.jand.2022.12.005","journal-title":"Journal of the Academy of Nutrition and Dietetics"},{"key":"488_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101869","volume":"42","author":"K Aleksandrova","year":"2021","unstructured":"Aleksandrova, K., Koelman, L., & Rodrigues, C. E. (2021). Dietary patterns and biomarkers of oxidative stress and inflammation: A systematic review of observational and intervention studies. Redox Biology, 42, Article 101869. https:\/\/doi.org\/10.1016\/j.redox.2021.101869","journal-title":"Redox Biology"},{"key":"488_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/nu10050642","author":"M Kujawska","year":"2018","unstructured":"Kujawska, M., & Jodynis-Liebert, J. (2018). Polyphenols in Parkinson\u2019s disease: A systematic review of in vivo studies. Nutrients. https:\/\/doi.org\/10.3390\/nu10050642","journal-title":"Nutrients"},{"key":"488_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309957","author":"FD Filippis","year":"2016","unstructured":"Filippis, F. D., Pellegrini, N., Vannini, L., Jeffery, I. B., Storia, A. L., Laghi, L., Serrazanetti, D. I., Cagno, R. D., Ferrocino, I., Lazzi, C., Turroni, S., Cocolin, L., Brigidi, P., Neviani, E., Gobbetti, M., O\u2019Toole, P. W., & Ercolini, D. (2016). High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut. https:\/\/doi.org\/10.1136\/gutjnl-2015-309957","journal-title":"Gut"},{"key":"488_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120166","volume":"434","author":"RJ Solch","year":"2022","unstructured":"Solch, R. J., Aigbogun, J. O., Voyiadjis, A. G., Talkington, G. M., Darensbourg, R. M., O\u2019Connell, S., Pickett, K. M., Perez, S. R., & Maraganore, D. M. (2022). Mediterranean diet adherence, gut microbiota, and Alzheimer\u2019s or Parkinson\u2019s disease risk: A systematic review. Journal of the Neurological Sciences, 434, Article 120166. https:\/\/doi.org\/10.1016\/j.jns.2022.120166","journal-title":"Journal of the Neurological Sciences"},{"issue":"23","key":"488_CR26","doi-asserted-by":"publisher","first-page":"e2157","DOI":"10.1212\/WNL.0000000000008567","volume":"93","author":"KC Hughes","year":"2019","unstructured":"Hughes, K. C., Gao, X., Molsberry, S., Valeri, L., Schwarzschild, M. A., & Ascherio, A. (2019). Physical activity and prodromal features of Parkinson disease. Neurology, 93(23), e2157\u2013e2169. https:\/\/doi.org\/10.1212\/WNL.0000000000008567","journal-title":"Neurology"},{"issue":"15","key":"488_CR27","doi-asserted-by":"publisher","first-page":"e2095","DOI":"10.1212\/WNL.0000000000010523","volume":"95","author":"S Molsberry","year":"2020","unstructured":"Molsberry, S., Bjornevik, K., Hughes, K. C., Healy, B., Schwarzschild, M., & Ascherio, A. (2020). Diet pattern and prodromal features of Parkinson disease. Neurology, 95(15), e2095\u2013e2108. https:\/\/doi.org\/10.1212\/WNL.0000000000010523","journal-title":"Neurology"},{"issue":"2","key":"488_CR28","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/ggi.12123","volume":"14","author":"H Qi","year":"2014","unstructured":"Qi, H., & Li, S. (2014). Dose\u2013response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson\u2019s disease. Geriatrics & Gerontology International, 14(2), 430\u2013439. https:\/\/doi.org\/10.1111\/ggi.12123","journal-title":"Geriatrics & Gerontology International"},{"issue":"6","key":"488_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/nu12061860","volume":"12","author":"CT Hong","year":"2020","unstructured":"Hong, C. T., Chan, L., & Bai, C.-H. (2020). The effect of caffeine on the risk and progression of Parkinson\u2019s disease: A meta-analysis. Nutrients, 12(6), Article 1860. https:\/\/doi.org\/10.3390\/nu12061860","journal-title":"Nutrients"},{"issue":"3","key":"488_CR30","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.archger.2015.08.004","volume":"61","author":"X Li","year":"2015","unstructured":"Li, X., Li, W., Liu, G., Shen, X., & Tang, Y. (2015). Association between cigarette smoking and Parkinson\u2019s disease: A meta-analysis. Archives of Gerontology and Geriatrics, 61(3), 510\u2013516. https:\/\/doi.org\/10.1016\/j.archger.2015.08.004","journal-title":"Archives of Gerontology and Geriatrics"},{"issue":"3","key":"488_CR31","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/ene.14607","volume":"28","author":"FJ Jim\u00e9nez-Jim\u00e9nez","year":"2021","unstructured":"Jim\u00e9nez-Jim\u00e9nez, F. J., Alonso-Navarro, H., Garc\u00eda-Mart\u00edn, E., & Ag\u00fandez, J. A. G. (2021). Biological fluid levels of iron and iron-related proteins in Parkinson\u2019s disease: Review and meta-analysis. European Journal of Neurology, 28(3), 1041\u20131055. https:\/\/doi.org\/10.1111\/ene.14607","journal-title":"European Journal of Neurology"},{"issue":"2","key":"488_CR32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1079\/NRR2005108","volume":"18","author":"L Ishihara","year":"2005","unstructured":"Ishihara, L., & Brayne, C. (2005). A systematic review of nutritional risk factors of Parkinson\u2019s disease. Nutrition Research Reviews, 18(2), 259\u2013282. https:\/\/doi.org\/10.1079\/NRR2005108","journal-title":"Nutrition Research Reviews"},{"issue":"6","key":"488_CR33","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ana.23687","volume":"72","author":"AJ Noyce","year":"2012","unstructured":"Noyce, A. J., Bestwick, J. P., Silveira-Moriyama, L., Hawkes, C. H., Giovannoni, G., Lees, A. J., & Schrag, A. (2012). Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Annals of Neurology, 72(6), 893\u2013901. https:\/\/doi.org\/10.1002\/ana.23687","journal-title":"Annals of Neurology"},{"issue":"6","key":"488_CR34","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/mds.25863","volume":"29","author":"D Zhang","year":"2014","unstructured":"Zhang, D., Jiang, H., & Xie, J. (2014). Alcohol intake and risk of Parkinson\u2019s disease: A meta-analysis of observational studies. Movement Disorders, 29(6), 819\u2013822. https:\/\/doi.org\/10.1002\/mds.25863","journal-title":"Movement Disorders"},{"key":"488_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.709846","volume":"8","author":"C Shao","year":"2021","unstructured":"Shao, C., Wang, X., Wang, P., Tang, H., He, J., & Wu, N. (2021). Parkinson\u2019s disease risk and alcohol intake: A systematic review and dose-response meta-analysis of prospective studies. Frontiers in Nutrition, 8, Article 709846. https:\/\/doi.org\/10.3389\/fnut.2021.709846","journal-title":"Frontiers in Nutrition"},{"issue":"8","key":"488_CR36","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.3233\/JPD-223522","volume":"12","author":"E Mitchell","year":"2022","unstructured":"Mitchell, E., Chohan, H., Bestwick, J. P., & Noyce, A. J. (2022). Alcohol and Parkinson\u2019s disease: A systematic review and meta-analysis. Journal of Parkinson\u2019s Disease, 12(8), 2369\u20132381. https:\/\/doi.org\/10.3233\/JPD-223522","journal-title":"Journal of Parkinson's Disease"},{"key":"488_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/mds.70200","author":"S Hemeda","year":"2026","unstructured":"Hemeda, S., Elmadani, M., Merzah, M., Odeh, A., Pint\u00e9r, E., Bal\u00e1s, I., Janszky, J., Pint\u00e9r, D., & Kov\u00e1cs, N. (2026). Impact of alcohol intake on Parkinson\u2019s disease risk and progression: A systematic review and dose\u2013response meta-analysis of prospective studies. Movement Disorders. https:\/\/doi.org\/10.1002\/mds.70200","journal-title":"Movement Disorders"},{"issue":"8","key":"488_CR38","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s00415-018-9032-3","volume":"266","author":"FJ Jim\u00e9nez-Jim\u00e9nez","year":"2019","unstructured":"Jim\u00e9nez-Jim\u00e9nez, F. J., Alonso-Navarro, H., Garc\u00eda-Mart\u00edn, E., & Ag\u00fandez, J. A. G. (2019). Alcohol consumption and risk for Parkinson\u2019s disease: A systematic review and meta-analysis. Journal of Neurology, 266(8), 1821\u20131834. https:\/\/doi.org\/10.1007\/s00415-018-9032-3","journal-title":"Journal of Neurology"},{"issue":"1","key":"488_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s42466-025-00452-6","volume":"7","author":"K Kulcs\u00e1rov\u00e1","year":"2025","unstructured":"Kulcs\u00e1rov\u00e1, K., Piel, J. H. A., & Schaeffer, E. (2025). Environmental toxins in neurodegeneration\u2014A narrative review. Neurological Research and Practice, 7(1), Article 93. https:\/\/doi.org\/10.1186\/s42466-025-00452-6","journal-title":"Neurological Research and Practice"},{"issue":"5","key":"488_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/19338244.2018.1492894","volume":"74","author":"W Tangamornsuksan","year":"2019","unstructured":"Tangamornsuksan, W., Lohitnavy, O., Sruamsiri, R., Chaiyakunapruk, N., Norman Scholfield, C., Reisfeld, B., & Lohitnavy, M. (2019). Paraquat exposure and Parkinson\u2019s disease: A systematic review and meta-analysis. Archives of Environmental & Occupational Health, 74(5), 225\u2013238. https:\/\/doi.org\/10.1080\/19338244.2018.1492894","journal-title":"Archives of Environmental & Occupational Health"},{"key":"488_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yrtph.2018.05.005","volume":"96","author":"D Yan","year":"2018","unstructured":"Yan, D., Zhang, Y., Liu, L., Shi, N., & Yan, H. (2018). Pesticide exposure and risk of Parkinson\u2019s disease: Dose-response meta-analysis of observational studies. Regulatory Toxicology and Pharmacology: RTP, 96, 57\u201363. https:\/\/doi.org\/10.1016\/j.yrtph.2018.05.005","journal-title":"Regulatory Toxicology and Pharmacology: RTP"},{"issue":"1","key":"488_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1515\/reveh-2021-0111","volume":"38","author":"T Chambers-Richards","year":"2023","unstructured":"Chambers-Richards, T., Su, Y., Chireh, B., & D\u2019Arcy, C. (2023). Exposure to toxic occupations and their association with Parkinson\u2019s disease: A systematic review with meta-analysis. Reviews on Environmental Health, 38(1), 65\u201383. https:\/\/doi.org\/10.1515\/reveh-2021-0111","journal-title":"Reviews on Environmental Health"},{"issue":"1","key":"488_CR43","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/taap.1996.0054","volume":"137","author":"HH Liou","year":"1996","unstructured":"Liou, H. H., Chen, R. C., Tsai, Y. F., Chen, W. P., Chang, Y. C., & Tsai, M. C. (1996). Effects of paraquat on the substantia nigra of the wistar rats: Neurochemical, histological, and behavioral studies. Toxicology and Applied Pharmacology, 137(1), 34\u201341. https:\/\/doi.org\/10.1006\/taap.1996.0054","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"6","key":"488_CR44","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1007\/s12035-022-02799-2","volume":"59","author":"WZC See","year":"2022","unstructured":"See, W. Z. C., Naidu, R., & Tang, K. S. (2022). Cellular and molecular events leading to paraquat-induced apoptosis: Mechanistic insights into Parkinson\u2019s disease pathophysiology. Molecular Neurobiology, 59(6), 3353\u20133369. https:\/\/doi.org\/10.1007\/s12035-022-02799-2","journal-title":"Molecular Neurobiology"},{"issue":"3","key":"488_CR45","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1074\/jbc.C100560200","volume":"277","author":"AB Manning-Bog","year":"2002","unstructured":"Manning-Bog, A. B., McCormack, A. L., Li, J., Uversky, V. N., Fink, A. L., & Di Monte, D. A. (2002). The Herbicide Paraquat Causes Up-regulation and Aggregation of \u03b1-Synuclein in Mice: PARAQUAT AND \u03b1-SYNUCLEIN*. Journal of Biological Chemistry, 277(3), 1641\u20131644. https:\/\/doi.org\/10.1074\/jbc.C100560200","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"488_CR46","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","volume":"34","author":"JR Cannon","year":"2009","unstructured":"Cannon, J. R., Tapias, V. M., Na, H. M., Honick, A. S., Drolet, R. E., & Greenamyre, J. T. (2009). A highly reproducible rotenone model of Parkinson\u2019s disease. Neurobiology of Disease, 34(2), 279\u2013290. https:\/\/doi.org\/10.1016\/j.nbd.2009.01.016","journal-title":"Neurobiology of Disease"},{"issue":"12","key":"488_CR47","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1289\/ehp.0900852","volume":"117","author":"NM Gatto","year":"2009","unstructured":"Gatto, N. M., Cockburn, M., Bronstein, J., Manthripragada, A. D., & Ritz, B. (2009). Well-water consumption and Parkinson\u2019s disease in rural California. Environmental Health Perspectives, 117(12), 1912\u20131918. https:\/\/doi.org\/10.1289\/ehp.0900852","journal-title":"Environmental Health Perspectives"},{"issue":"12","key":"488_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15122885","volume":"15","author":"M Caballero","year":"2018","unstructured":"Caballero, M., Amiri, S., Denney, J. T., Monsivais, P., Hystad, P., & Amram, O. (2018). Estimated Residential Exposure to Agricultural Chemicals and Premature Mortality by Parkinson\u2019s Disease in Washington State. International Journal of Environmental Research and Public Health, 15(12), Article 2885. https:\/\/doi.org\/10.3390\/ijerph15122885","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"1","key":"488_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38215-z","volume":"14","author":"KC Paul","year":"2023","unstructured":"Paul, K. C., Krolewski, R. C., Lucumi Moreno, E., Blank, J., Holton, K. M., Ahfeldt, T., Furlong, M., Yu, Y., Cockburn, M., Thompson, L. K., Kreymerman, A., Ricci-Blair, E. M., Li, Y. J., Patel, H. B., Lee, R. T., Bronstein, J., Rubin, L. L., Khurana, V., & Ritz, B. (2023). A pesticide and iPSC dopaminergic neuron screen identifies and classifies Parkinson-relevant pesticides. Nature Communications, 14(1), Article 1. https:\/\/doi.org\/10.1038\/s41467-023-38215-z","journal-title":"Nature Communications"},{"issue":"5","key":"488_CR50","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.9198","volume":"8","author":"B Krzyzanowski","year":"2025","unstructured":"Krzyzanowski, B., Mullan, A. F., Dorsey, E. R., Chirag, S. S., Turcano, P., Camerucci, E., Bower, J. H., & Savica, R. (2025). Proximity to Golf Courses and Risk of Parkinson Disease. JAMA Network Open, 8(5), Article e259198. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.9198","journal-title":"JAMA Network Open"},{"issue":"7","key":"488_CR51","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2023.1168","volume":"80","author":"SM Goldman","year":"2023","unstructured":"Goldman, S. M., Weaver, F. M., Stroupe, K. T., Cao, L., Gonzalez, B., Colletta, K., Brown, E. G., & Tanner, C. M. (2023). Risk of Parkinson disease among service members at Marine Corps Base Camp Lejeune. JAMA Neurology, , Article e231168. https:\/\/doi.org\/10.1001\/jamaneurol.2023.1168","journal-title":"JAMA Neurology"},{"key":"488_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134437","volume":"711","author":"PC Keane","year":"2019","unstructured":"Keane, P. C., Hanson, P. S., Patterson, L., Blain, P. G., Hepplewhite, P., Khundakar, A. A., Judge, S. J., Kahle, P. J., LeBeau, F. E. N., & Morris, C. M. (2019). Trichloroethylene and its metabolite TaClo lead to degeneration of substantia nigra dopaminergic neurones: Effects in wild type and human A30P mutant \u03b1-synuclein mice. Neuroscience Letters, 711, Article 134437. https:\/\/doi.org\/10.1016\/j.neulet.2019.134437","journal-title":"Neuroscience Letters"},{"issue":"2","key":"488_CR53","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/toxsci\/kfad090","volume":"196","author":"A Adamson","year":"2023","unstructured":"Adamson, A., Ilieva, N., Stone, W. J., & De Miranda, B. R. (2023). Low-dose inhalation exposure to trichloroethylene induces dopaminergic neurodegeneration in rodents. Toxicological Sciences: An Official Journal of the Society of Toxicology, 196(2), 218\u2013228. https:\/\/doi.org\/10.1093\/toxsci\/kfad090","journal-title":"Toxicological Sciences: An Official Journal of the Society of Toxicology"},{"key":"488_CR54","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.scitotenv.2018.11.218","volume":"655","author":"P Fu","year":"2019","unstructured":"Fu, P., Guo, X., Cheung, F. M. H., & Yung, K. K. L. (2019). The association between PM2.5 exposure and neurological disorders: A systematic review and meta-analysis. Science of the Total Environment, 655, 1240\u20131248. https:\/\/doi.org\/10.1016\/j.scitotenv.2018.11.218","journal-title":"Science of the Total Environment"},{"issue":"14","key":"488_CR55","doi-asserted-by":"publisher","first-page":"39418","DOI":"10.1007\/s11356-023-25731-0","volume":"30","author":"Y Gong","year":"2023","unstructured":"Gong, Y., Zhang, X., Zhao, X., Chang, H., Zhang, J., Gao, Z., Mi, Y., Chen, Y., Zhang, H., Huang, C., & Yu, Z. (2023). Global ambient particulate matter pollution and neurodegenerative disorders: A systematic review of literature and meta-analysis. Environmental Science and Pollution Research International, 30(14), 39418\u201339430. https:\/\/doi.org\/10.1007\/s11356-023-25731-0","journal-title":"Environmental Science and Pollution Research International"},{"issue":"7","key":"488_CR56","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1007\/s10653-019-00484-3","volume":"42","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Liu, Y., & Yan, H. (2020). Effect of long-term particulate matter exposure on Parkinson\u2019s risk. Environmental Geochemistry and Health, 42(7), 2265\u20132275. https:\/\/doi.org\/10.1007\/s10653-019-00484-3","journal-title":"Environmental Geochemistry and Health"},{"key":"488_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2023.133289","volume":"465","author":"A Jeong","year":"2024","unstructured":"Jeong, A., Park, S. J., Lee, E. J., & Kim, K. W. (2024). Nanoplastics exacerbate Parkinson\u2019s disease symptoms in C. elegans and human cells. Journal of Hazardous Materials, 465, Article 133289. https:\/\/doi.org\/10.1016\/j.jhazmat.2023.133289","journal-title":"Journal of Hazardous Materials"},{"issue":"1","key":"488_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12989-023-00556-4","volume":"20","author":"Y Huang","year":"2023","unstructured":"Huang, Y., Liang, B., Li, Z., Zhong, Y., Wang, B., Zhang, B., Du, J., Ye, R., Xian, H., Min, W., Yan, X., Deng, Y., Feng, Y., Bai, R., Fan, B., Yang, X., & Huang, Z. (2023). Polystyrene nanoplastic exposure induces excessive mitophagy by activating AMPK\/ULK1 pathway in differentiated SH-SY5Y cells and dopaminergic neurons in vivo. Particle and Fibre Toxicology, 20(1), Article 44. https:\/\/doi.org\/10.1186\/s12989-023-00556-4","journal-title":"Particle and Fibre Toxicology"},{"issue":"46","key":"488_CR59","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi8716","volume":"9","author":"Z Liu","year":"2023","unstructured":"Liu, Z., Sokratian, A., Duda, A. M., Xu, E., Stanhope, C., Fu, A., Strader, S., Li, H., Yuan, Y., Bobay, B. G., Sipe, J., Bai, K., Lundgaard, I., Liu, N., Hernandez, B., Bowes Rickman, C., Miller, S. E., & West, A. B. (2023). Anionic nanoplastic contaminants promote Parkinson\u2019s disease-associated \u03b1-synuclein aggregation. Science Advances, 9(46), Article eadi8716. https:\/\/doi.org\/10.1126\/sciadv.adi8716","journal-title":"Science Advances"},{"issue":"5","key":"488_CR60","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1007\/s10072-023-07204-x","volume":"45","author":"N Shokri-Mashhadi","year":"2024","unstructured":"Shokri-Mashhadi, N., Ghiasvand, R., Feizi, A., Ebrahimi-Monfared, M., Vahid, F., & Banijamali, A. (2024). Association between major dietary patterns and Parkinson\u2019s disease risk: A case-control study. Neurological Sciences\u202f: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 45(5), 2003\u20132010. https:\/\/doi.org\/10.1007\/s10072-023-07204-x","journal-title":"Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"1","key":"488_CR61","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000527537","volume":"86","author":"S Xu","year":"2023","unstructured":"Xu, S., Li, W., & Di, Q. (2023). Association of dietary patterns with Parkinson\u2019s Disease: A cross-sectional study based on the United States National Health and Nutritional Examination Survey Database. European Neurology, 86(1), 63\u201372. https:\/\/doi.org\/10.1159\/000527537","journal-title":"European Neurology"},{"key":"488_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.101208","author":"EM Gonz\u00e1lez-Gil","year":"2025","unstructured":"Gonz\u00e1lez-Gil, E. M., Matta, M., Berstein, F. M., Cairat, M., Nicolas, G., Blanco, J., Kliemann, N., Levy, R. B., Rauber, F., Jacobs, I., Nahas, A. A., Cakmak, E. K., Vamos, E. P., Chang, K., Yammine, S. G., Millett, C., Touvier, M., Pinho, M. G. M., Tsilidis, K. K., & Huybrechts, I. (2025). Associations between degree of food processing and all-cause and cause-specific mortality: A multicentre prospective cohort analysis in 9 European countries. The Lancet Regional Health \u2013 Europe. https:\/\/doi.org\/10.1016\/j.lanepe.2024.101208","journal-title":"The Lancet Regional Health \u2013 Europe"},{"key":"488_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2019.110609","volume":"71","author":"EE Mart\u00ednez Leo","year":"2020","unstructured":"Mart\u00ednez Leo, E. E., & Segura Campos, M. R. (2020). Effect of ultra-processed diet on gut microbiota and thus its role in neurodegenerative diseases. Nutrition (Burbank, Los Angeles County, Calif.), 71, Article 110609. https:\/\/doi.org\/10.1016\/j.nut.2019.110609","journal-title":"Nutrition (Burbank, Los Angeles County, Calif.)"},{"issue":"1","key":"488_CR64","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/1028415X.2024.2351320","volume":"28","author":"A Pourmotabbed","year":"2025","unstructured":"Pourmotabbed, A., Talebi, S., Mehrabani, S., Babaei, A., Khosroshahi, R. A., Bagheri, R., Wong, A., Ghoreishy, S. M., Amirian, P., Zarpoosh, M., Hojjati Kermani, M. A., & Moradi, S. (2025). The association of ultra-processed food intake with neurodegenerative disorders: A systematic review and dose-response meta-analysis of large-scale cohorts. Nutritional Neuroscience, 28(1), 73\u201386. https:\/\/doi.org\/10.1080\/1028415X.2024.2351320","journal-title":"Nutritional Neuroscience"},{"key":"488_CR65","doi-asserted-by":"publisher","unstructured":"Chen, X., Wang, P., Luo, W., Wang, J., Sun, L., Li, Y., Zhang, F., & Gao, X. (2025). Association of ultra-processed food consumption with prodromal, incident Parkinson\u2019s disease and mortality. Journal of Neurology Neurosurgery and Psychiatry, jnnp-2025-336045. https:\/\/doi.org\/10.1136\/jnnp-2025-336045","DOI":"10.1136\/jnnp-2025-336045"},{"issue":"11","key":"488_CR66","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213562","volume":"104","author":"P Wang","year":"2025","unstructured":"Wang, P., Chen, X., Na, M., Flores-Torres, M. H., Bjornevik, K., Zhang, X., Chen, X., Khandpur, N., Rossato, S. L., Zhang, F. F., Ascherio, A., & Gao, X. (2025). Long-term consumption of ultraprocessed foods and prodromal features of Parkinson disease. Neurology, 104(11), Article e213562. https:\/\/doi.org\/10.1212\/WNL.0000000000213562","journal-title":"Neurology"},{"issue":"4","key":"488_CR67","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s13760-023-02209-x","volume":"123","author":"M Balabandian","year":"2023","unstructured":"Balabandian, M., Noori, M., Lak, B., Karimizadeh, Z., & Nabizadeh, F. (2023). Traumatic brain injury and risk of Parkinson\u2019s disease: A meta-analysis. Acta Neurologica Belgica, 123(4), 1225\u20131239. https:\/\/doi.org\/10.1007\/s13760-023-02209-x","journal-title":"Acta Neurologica Belgica"},{"issue":"1","key":"488_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-018-1187-0","volume":"18","author":"C-H Huang","year":"2018","unstructured":"Huang, C.-H., Lin, C.-W., Lee, Y.-C., Huang, C.-Y., Huang, R.-Y., Tai, Y.-C., Wang, K.-W., Yang, S.-N., Sun, Y.-T., & Wang, H.-K. (2018). Is traumatic brain injury a risk factor for neurodegeneration? A meta-analysis of population-based studies. BMC Neurology, 18(1), Article 184. https:\/\/doi.org\/10.1186\/s12883-018-1187-0","journal-title":"BMC Neurology"},{"issue":"2","key":"488_CR69","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3171\/2015.2.JNS14503","volume":"124","author":"DC Perry","year":"2016","unstructured":"Perry, D. C., Sturm, V. E., Peterson, M. J., Pieper, C. F., Bullock, T., Boeve, B. F., Miller, B. L., Guskiewicz, K. M., Berger, M. S., Kramer, J. H., & Welsh-Bohmer, K. A. (2016). Association of traumatic brain injury with subsequent neurological and psychiatric disease: A meta-analysis. Journal of Neurosurgery, 124(2), 511\u2013526. https:\/\/doi.org\/10.3171\/2015.2.JNS14503","journal-title":"Journal of Neurosurgery"},{"issue":"3 Suppl","key":"488_CR70","doi-asserted-by":"publisher","first-page":"S238","DOI":"10.1016\/j.apmr.2013.08.298","volume":"95","author":"C Marras","year":"2014","unstructured":"Marras, C., Hincapi\u00e9, C. A., Kristman, V. L., Cancelliere, C., Soklaridis, S., Li, A., Borg, J., af Geijerstam, J.-L., & Cassidy, J. D. (2014). Systematic review of the risk of Parkinson\u2019s disease after mild traumatic brain injury: Results of the International Collaboration on Mild Traumatic Brain Injury Prognosis. Archives of Physical Medicine and Rehabilitation, 95(3 Suppl), S238-244. https:\/\/doi.org\/10.1016\/j.apmr.2013.08.298","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"9","key":"488_CR71","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1002\/mds.25458","volume":"28","author":"S Jafari","year":"2013","unstructured":"Jafari, S., Etminan, M., Aminzadeh, F., & Samii, A. (2013). Head injury and risk of Parkinson disease: A systematic review and meta-analysis. Movement Disorders\u202f: Official Journal of the Movement Disorder Society, 28(9), 1222\u20131229. https:\/\/doi.org\/10.1002\/mds.25458","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"issue":"12","key":"488_CR72","doi-asserted-by":"publisher","first-page":"6667","DOI":"10.1007\/s10072-022-06319-x","volume":"43","author":"G Bellomo","year":"2022","unstructured":"Bellomo, G., Piscopo, P., Corbo, M., Pupillo, E., Stipa, G., Beghi, E., Vanacore, N., & Lacorte, E. (2022). A systematic review on the risk of neurodegenerative diseases and neurocognitive disorders in professional and varsity athletes. Neurological Sciences\u202f: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 43(12), 6667\u20136691. https:\/\/doi.org\/10.1007\/s10072-022-06319-x","journal-title":"Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"1","key":"488_CR73","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/ana.22499","volume":"71","author":"SM Goldman","year":"2012","unstructured":"Goldman, S. M., Kamel, F., Ross, G. W., Jewell, S. A., Bhudhikanok, G. S., Umbach, D., Marras, C., Hauser, R. A., Jankovic, J., Factor, S. A., Bressman, S., Lyons, K. E., Meng, C., Korell, M., Roucoux, D. F., Hoppin, J. A., Sandler, D. P., Langston, J. W., & Tanner, C. M. (2012). Head injury, \u03b1-synuclein Rep1, and Parkinson\u2019s disease. Annals of Neurology, 71(1), 40\u201348. https:\/\/doi.org\/10.1002\/ana.22499","journal-title":"Annals of Neurology"},{"issue":"7","key":"488_CR74","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12694","volume":"22","author":"SM Goldman","year":"2015","unstructured":"Goldman, S. M., Umbach, D. M., Kamel, F., & Tanner, C. M. (2015). Head injury, \u03b1-synuclein Rep1 and Parkinson\u2019s disease: A meta-analytic view of gene-environment interaction. European Journal of Neurology, 22(7), Article e75. https:\/\/doi.org\/10.1111\/ene.12694","journal-title":"European Journal of Neurology"},{"issue":"7","key":"488_CR75","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1001\/archneur.64.7.990","volume":"64","author":"B Ritz","year":"2007","unstructured":"Ritz, B., Ascherio, A., Checkoway, H., Marder, K. S., Nelson, L. M., Rocca, W. A., Ross, G. W., Strickland, D., Van Den Eeden, S. K., & Gorell, J. (2007). Pooled analysis of tobacco use and risk of Parkinson disease. Archives of Neurology, 64(7), 990\u2013997. https:\/\/doi.org\/10.1001\/archneur.64.7.990","journal-title":"Archives of Neurology"},{"issue":"7","key":"488_CR76","doi-asserted-by":"publisher","first-page":"e583","DOI":"10.1212\/WNL.0000000000004953","volume":"90","author":"P-C Lee","year":"2018","unstructured":"Lee, P.-C., Ahmed, I., Loriot, M.-A., Mulot, C., Paul, K. C., Bronstein, J. M., Ritz, B., & Elbaz, A. (2018). Smoking and Parkinson disease: Evidence for gene-by-smoking interactions. Neurology, 90(7), e583\u2013e592. https:\/\/doi.org\/10.1212\/WNL.0000000000004953","journal-title":"Neurology"},{"issue":"5","key":"488_CR77","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/ana.25065","volume":"82","author":"Y-H Chuang","year":"2017","unstructured":"Chuang, Y.-H., Lee, P.-C., Vlaar, T., Mulot, C., Loriot, M.-A., Hansen, J., Lill, C. M., Ritz, B., & Elbaz, A. (2017). Pooled analysis of the HLA-DRB1 by smoking interaction in Parkinson disease. Annals of Neurology, 82(5), 655\u2013664. https:\/\/doi.org\/10.1002\/ana.25065","journal-title":"Annals of Neurology"},{"issue":"4","key":"488_CR78","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/ana.26852","volume":"95","author":"A Reynoso","year":"2024","unstructured":"Reynoso, A., Torricelli, R., Jacobs, B. M., Shi, J., Aslibekyan, S., Norcliffe-Kaufmann, L., Noyce, A. J., & Heilbron, K. (2024). Gene-environment interactions for Parkinson\u2019s Disease. Annals of Neurology, 95(4), 677\u2013687. https:\/\/doi.org\/10.1002\/ana.26852","journal-title":"Annals of Neurology"},{"issue":"10","key":"488_CR79","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1002\/mds.29563","volume":"38","author":"T L\u00fcth","year":"2023","unstructured":"L\u00fcth, T., Gabbert, C., Koch, S., K\u00f6nig, I. R., Caliebe, A., Laabs, B. H., Hentati, F., Sassi, S. B., Amouri, R., Spielmann, M., Klein, C., Gr\u00fcnewald, A., Farrer, M. J., & Trinh, J. (2023). Interaction of mitochondrial polygenic score and lifestyle factors in LRRK2 p.Gly2019Ser Parkinsonism. Movement Disorders\u202f: Official Journal of the Movement Disorder Society, 38(10), 1837\u20131849. https:\/\/doi.org\/10.1002\/mds.29563","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"issue":"7","key":"488_CR80","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/sj.ejcn.1602788","volume":"62","author":"K S\u00e4\u00e4ksj\u00e4rvi","year":"2008","unstructured":"S\u00e4\u00e4ksj\u00e4rvi, K., Knekt, P., Rissanen, H., Laaksonen, M. A., Reunanen, A., & M\u00e4nnist\u00f6, S. (2008). Prospective study of coffee consumption and risk of Parkinson\u2019s disease. European Journal of Clinical Nutrition, 62(7), 908\u2013915. https:\/\/doi.org\/10.1038\/sj.ejcn.1602788","journal-title":"European Journal of Clinical Nutrition"},{"key":"488_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102381","volume":"99","author":"Y Yang","year":"2024","unstructured":"Yang, Y., Zhou, Z. D., Yi, L., Tan, B.-W., & Tan, E.-K. (2024). Interaction between caffeine consumption & genetic susceptibility in Parkinson\u2019s disease: A systematic review. Ageing Research Reviews, 99, Article 102381. https:\/\/doi.org\/10.1016\/j.arr.2024.102381","journal-title":"Ageing Research Reviews"},{"key":"488_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2023.100877","volume":"40","author":"Y-L Ong","year":"2023","unstructured":"Ong, Y.-L., Deng, X., Li, H.-H., Narasimhalu, K., Chan, L.-L., Prakash, K. M., Au, W.-L., Ratnagopal, P., Tan, L. C. S., & Tan, E.-K. (2023). Caffeine intake interacts with Asian gene variants in Parkinson\u2019s disease: A study in 4488 subjects. The Lancet Regional Health. Western Pacific, 40, Article 100877. https:\/\/doi.org\/10.1016\/j.lanwpc.2023.100877","journal-title":"The Lancet Regional Health. Western Pacific"},{"issue":"12","key":"488_CR83","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1212\/WNL.0b013e3181d5a4a3","volume":"74","author":"JJ Gagne","year":"2010","unstructured":"Gagne, J. J., & Power, M. C. (2010). Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysis. Neurology, 74(12), 995\u20131002. https:\/\/doi.org\/10.1212\/WNL.0b013e3181d5a4a3","journal-title":"Neurology"},{"issue":"10","key":"488_CR84","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/mds.28189","volume":"35","author":"M San Luciano","year":"2020","unstructured":"San Luciano, M., Tanner, C. M., Meng, C., Marras, C., Goldman, S. M., Lang, A. E., Tolosa, E., Sch\u00fcle, B., Langston, J. W., Brice, A., Corvol, J.-C., Goldwurm, S., Klein, C., Brockman, S., Berg, D., Brockmann, K., Ferreira, J. J., Tazir, M., Mellick, G. D., \u2026 Michael J. Fox Foundation LRRK2 Cohort Consortium. (2020). Nonsteroidal anti-inflammatory use and LRRK2 Parkinson\u2019s disease penetrance. Movement Disorders, 35(10), 1755\u20131764. https:\/\/doi.org\/10.1002\/mds.28189","journal-title":"Movement Disorders"},{"issue":"1","key":"488_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-65640-x","volume":"14","author":"C Gabbert","year":"2024","unstructured":"Gabbert, C., Bl\u00f6baum, L., L\u00fcth, T., K\u00f6nig, I. R., Caliebe, A., Sendel, S., Laabs, B.-H., Klein, C., & Trinh, J. (2024). The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson\u2019s disease. Scientific Reports, 14(1), Article 14670. https:\/\/doi.org\/10.1038\/s41598-024-65640-x","journal-title":"Scientific Reports"},{"issue":"5","key":"488_CR86","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1001\/jamaneurol.2023.0183","volume":"80","author":"Z Zheng","year":"2023","unstructured":"Zheng, Z., Lv, Y., Rong, S., Sun, T., & Chen, L. (2023). Physical frailty, genetic predisposition, and incident Parkinson disease. JAMA Neurology, 80(5), 455\u2013461. https:\/\/doi.org\/10.1001\/jamaneurol.2023.0183","journal-title":"JAMA Neurology"},{"key":"488_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mad.2018.04.004","volume":"173","author":"KC Paul","year":"2018","unstructured":"Paul, K. C., Sinsheimer, J. S., Cockburn, M., Bronstein, J. M., Bordelon, Y., & Ritz, B. (2018). NFE2L2, PPARGC1\u03b1, and pesticides and Parkinson\u2019s disease risk and progression. Mechanisms of Ageing and Development, 173, 1\u20138. https:\/\/doi.org\/10.1016\/j.mad.2018.04.004","journal-title":"Mechanisms of Ageing and Development"},{"issue":"6","key":"488_CR88","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1289\/ehp.0800277","volume":"117","author":"BR Ritz","year":"2009","unstructured":"Ritz, B. R., Manthripragada, A. D., Costello, S., Lincoln, S. J., Farrer, M. J., Cockburn, M., & Bronstein, J. (2009). Dopamine transporter genetic variants and pesticides in Parkinson\u2019s disease. Environmental Health Perspectives, 117(6), 964\u2013969. https:\/\/doi.org\/10.1289\/ehp.0800277","journal-title":"Environmental Health Perspectives"},{"key":"488_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105312","volume":"153","author":"BR De Miranda","year":"2021","unstructured":"De Miranda, B. R., Castro, S. L., Rocha, E. M., Bodle, C. R., Johnson, K. E., & Greenamyre, J. T. (2021). The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson\u2019s disease. Neurobiology of Disease, 153, Article 105312. https:\/\/doi.org\/10.1016\/j.nbd.2021.105312","journal-title":"Neurobiology of Disease"},{"issue":"1","key":"488_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.117434","volume":"240","author":"D Kwon","year":"2024","unstructured":"Kwon, D., Paul, K. C., Yu, Y., Zhang, K., Folle, A. D., Wu, J., Bronstein, J. M., & Ritz, B. (2024). Traffic-related air pollution and Parkinson\u2019s disease in central California. Environmental Research, 240(1), Article 117434. https:\/\/doi.org\/10.1016\/j.envres.2023.117434","journal-title":"Environmental Research"},{"issue":"3","key":"488_CR91","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1474-4422(20)30449-X","volume":"20","author":"A Iranzo","year":"2021","unstructured":"Iranzo, A., Fairfoul, G., Ayudhaya, A. C. N., Serradell, M., Gelpi, E., Vilaseca, I., Sanchez-Valle, R., Gaig, C., Santamaria, J., Tolosa, E., Riha, R. L., & Green, A. J. E. (2021). Detection of \u03b1-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: A longitudinal observational study. The Lancet Neurology, 20(3), 203\u2013212. https:\/\/doi.org\/10.1016\/S1474-4422(20)30449-X","journal-title":"The Lancet Neurology"},{"issue":"5","key":"488_CR92","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000210279","volume":"104","author":"DG Coughlin","year":"2025","unstructured":"Coughlin, D. G., Shifflett, B., Farris, C. M., Ma, Y., Galasko, D., Edland, S. D., Mollenhauer, B., Brumm, M. C., Poston, K. L., Marek, K., Siderowf, A. D., Soto, C., Concha-Marambio, L., Investigators of the Parkinson\u2019s Progression Marker Initiative. (2025). \u03b1-Synuclein seed amplification assay amplification parameters and the risk of progression in prodromal Parkinson disease. Neurology, 104(5), Article e210279. https:\/\/doi.org\/10.1212\/WNL.0000000000210279","journal-title":"Neurology"},{"issue":"1","key":"488_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-024-08265-9","volume":"25","author":"A Ophey","year":"2024","unstructured":"Ophey, A., R\u00f6ttgen, S., Pauquet, J., Wei\u00df, K.-L., Scharfenberg, D., Doppler, C. E. J., Seger, A., Hansen, C., Fink, G. R., Sommerauer, M., & Kalbe, E. (2024). Cognitive training and promoting a healthy lifestyle for individuals with isolated REM sleep behavior disorder: Study protocol of the delayed-start randomized controlled trial CogTrAiL-RBD. Trials, 25(1), Article 428. https:\/\/doi.org\/10.1186\/s13063-024-08265-9","journal-title":"Trials"},{"key":"488_CR94","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.prdoa.2019.07.004","volume":"1","author":"MR Landers","year":"2019","unstructured":"Landers, M. R., Johnson, K. N., Johnson, S., Ormsby, T., Salgo, D. C., Zorn, J. B., Lyle, J., Murtishaw, A. S., Salazar, A. M., & Kinney, J. W. (2019). Pre-diagnosis physical activity habits are associated with age of diagnosis in Parkinson\u2019s disease. Clinical Parkinsonism & Related Disorders, 1, 25\u201330. https:\/\/doi.org\/10.1016\/j.prdoa.2019.07.004","journal-title":"Clinical Parkinsonism & Related Disorders"},{"issue":"4","key":"488_CR95","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/mds.28464","volume":"36","author":"A Metcalfe-Roach","year":"2021","unstructured":"Metcalfe-Roach, A., Yu, A. C., Golz, E., Cirstea, M., Sundvick, K., Kliger, D., Foulger, L. H., Mackenzie, M., Finlay, B. B., & Appel-Cresswell, S. (2021). MIND and Mediterranean diets associated with later onset of Parkinson\u2019s disease. Movement Disorders, 36(4), 977\u2013984. https:\/\/doi.org\/10.1002\/mds.28464","journal-title":"Movement Disorders"},{"issue":"19","key":"488_CR96","doi-asserted-by":"publisher","first-page":"e2037","DOI":"10.1212\/WNL.0000000000009400","volume":"94","author":"E Schaeffer","year":"2020","unstructured":"Schaeffer, E., Rogge, A., Nieding, K., Helmker, V., Letsch, C., Hauptmann, B., & Berg, D. (2020). Patients\u2019 views on the ethical challenges of early Parkinson disease detection. Neurology, 94(19), e2037\u2013e2044. https:\/\/doi.org\/10.1212\/WNL.0000000000009400","journal-title":"Neurology"},{"issue":"6","key":"488_CR97","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/mds.29403","volume":"38","author":"L P\u00e9rez-Carbonell","year":"2023","unstructured":"P\u00e9rez-Carbonell, L., Simonet, C., Chohan, H., Gill, A., Leschziner, G., Schrag, A., & Noyce, A. J. (2023). The views of patients with isolated rapid eye movement sleep behavior disorder on risk disclosure. Movement Disorders, 38(6), 1089\u20131093. https:\/\/doi.org\/10.1002\/mds.29403","journal-title":"Movement Disorders"},{"issue":"1","key":"488_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-00979-0","volume":"11","author":"S R\u00f6ttgen","year":"2025","unstructured":"R\u00f6ttgen, S., Schaeffer, E., Rogge, A., Hartung, R., Kufer, K., Fink, G. R., Berg, D., Ophey, A., & Sommerauer, M. (2025). The prodromal individuals\u2019 perspective on active recruitment for early detection of \u03b1-synucleinopathies. NPJ Parkinson\u2019s Disease, 11(1), Article 121. https:\/\/doi.org\/10.1038\/s41531-025-00979-0","journal-title":"NPJ Parkinson's Disease"},{"issue":"1","key":"488_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Ray Chaudhuri, K., & Weintraub, D. (2021). Parkinson disease-associated cognitive impairment. Nature Reviews Disease Primers, 7(1), 1\u201321. https:\/\/doi.org\/10.1038\/s41572-021-00280-3","journal-title":"Nature Reviews Disease Primers"},{"issue":"1","key":"488_CR100","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.27902","volume":"35","author":"C Baiano","year":"2020","unstructured":"Baiano, C., Barone, P., Trojano, L., & Santangelo, G. (2020). Prevalence and clinical aspects of mild cognitive impairment in Parkinson\u2019s disease: A meta-analysis. Movement Disorders\u202f: Official Journal of the Movement Disorder Society, 35(1), 45\u201354. https:\/\/doi.org\/10.1002\/mds.27902","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"issue":"4","key":"488_CR101","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1212\/WNL.0000000000000066","volume":"82","author":"AJ Yarnall","year":"2014","unstructured":"Yarnall, A. J., Breen, D. P., Duncan, G. W., Khoo, T. K., Coleman, S. Y., Firbank, M. J., Nombela, C., Winder-Rhodes, S., Evans, J. R., Rowe, J. B., Mollenhauer, B., Kruse, N., Hudson, G., Chinnery, P. F., O\u2019Brien, J. T., Robbins, T. W., Wesnes, K., Brooks, D. J., Barker, R. A., ICICLE-PD Study Group. (2014). Characterizing mild cognitive impairment in incident Parkinson disease: The ICICLE-PD study. Neurology, 82(4), 308\u2013316. https:\/\/doi.org\/10.1212\/WNL.0000000000000066","journal-title":"Neurology"},{"issue":"5","key":"488_CR102","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209699","volume":"103","author":"J Gallagher","year":"2024","unstructured":"Gallagher, J., Gochanour, C., Caspell-Garcia, C., Dobkin, R. D., Aarsland, D., Alcalay, R. N., Barrett, M. J., Chahine, L., Chen-Plotkin, A. S., Coffey, C. S., Dahodwala, N., Eberling, J. L., Espay, A. J., Leverenz, J. B., Litvan, I., Mamikonyan, E., Morley, J., Richard, I. H., Rosenthal, L., \u2026 Razzaque, J. (2024). Long-Term Dementia Risk in Parkinson Disease. Neurology, 103(5), Article e209699. https:\/\/doi.org\/10.1212\/WNL.0000000000209699","journal-title":"Neurology"},{"issue":"1","key":"488_CR103","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11065-022-09572-1","volume":"34","author":"C Leitner","year":"2024","unstructured":"Leitner, C., D\u2019Este, G., Verga, L., Rahayel, S., Mombelli, S., Sforza, M., Casoni, F., Zucconi, M., Ferini-Strambi, L., & Galbiati, A. (2024). Neuropsychological changes in isolated REM sleep behavior disorder: A systematic review and meta-analysis of cross-sectional and longitudinal studies. Neuropsychology Review, 34(1), 41\u201366. https:\/\/doi.org\/10.1007\/s11065-022-09572-1","journal-title":"Neuropsychology Review"},{"issue":"8","key":"488_CR104","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1093\/brain\/awad072","volume":"146","author":"S Joza","year":"2023","unstructured":"Joza, S., Hu, M. T., Jung, K.-Y., Kunz, D., Stefani, A., Du\u0161ek, P., Terzaghi, M., Arnaldi, D., Videnovic, A., Schiess, M. C., Hermann, W., Lee, J.-Y., Ferini-Strambi, L., Lewis, S. J. G., Leclair-Visonneau, L., Oertel, W. H., Antelmi, E., Sixel-D\u00f6ring, F., Cochen De Cock, V., \u2026 Postuma, R. B. (2023). Progression of clinical markers in prodromal Parkinson\u2019s disease and dementia with Lewy bodies: A multicentre study. Brain, 146(8), 3258\u20133272. https:\/\/doi.org\/10.1093\/brain\/awad072","journal-title":"Brain"},{"issue":"8","key":"488_CR105","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1177\/1877718X251365769","volume":"15","author":"E Kalbe","year":"2025","unstructured":"Kalbe, E., Warnecke, T., Eggers, C., Ophey, A., & Folkerts, A. K. (2025). Prevention of cognitive impairment and dementia in people with Parkinson\u2019s disease: A call-to-action. Journal of Parkinson\u2019s Disease, 15(8), 1353\u20131366. https:\/\/doi.org\/10.1177\/1877718X251365769","journal-title":"Journal of Parkinson's Disease"},{"issue":"11","key":"488_CR106","doi-asserted-by":"publisher","first-page":"7330","DOI":"10.1007\/s00415-024-12503-0","volume":"271","author":"E Kalbe","year":"2024","unstructured":"Kalbe, E., Folkerts, A.-K., Witt, K., Buhmann, C., Liepelt-Scarfone, I., German Parkinson\u2019s Guidelines Group. (2024). German Society of Neurology guidelines for the diagnosis and treatment of cognitive impairment and affective disorders in people with Parkinson\u2019s disease: New spotlights on diagnostic procedures and non-pharmacological interventions. Journal of Neurology, 271(11), 7330\u20137357. https:\/\/doi.org\/10.1007\/s00415-024-12503-0","journal-title":"Journal of Neurology"},{"issue":"10452","key":"488_CR107","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selb\u00e6k, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., Fox, N. C., Ferri, C. P., Gitlin, L. N., Howard, R., Kales, H. C., Kivim\u00e4ki, M., Larson, E. B., Nakasujja, N., Rockwood, K., \u2026 Mukadam, N. (2024). Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet (London, England), 404(10452), 572\u2013628. https:\/\/doi.org\/10.1016\/S0140-6736(24)01296-0","journal-title":"Lancet (London, England)"},{"key":"488_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105950","volume":"120","author":"CM Mostert","year":"2025","unstructured":"Mostert, C. M., Udeh-Momoh, C., Winkler, A. S., McLaughlin, C., Eyre, H., Salama, M., Ranchod, K., Trepel, D., Vradenburg, G., Hynes, W., Fieggen, G., Ali, S., Mekkaoui, N. E. L., Landay, A., Bobrow, K., Muyela, L., Atkins, K., Chadha, A. S., Marongiu, R., \u2026 Ibanez, A. (2025). Broadening dementia risk models: Building on the 2024 Lancet Commission report for a more inclusive global framework. EBioMedicine, 120, Article 105950. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105950","journal-title":"EBioMedicine"},{"issue":"1","key":"488_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02485-1","volume":"21","author":"S Mart\u00ednez-Horta","year":"2021","unstructured":"Mart\u00ednez-Horta, S., Bejr-Kasem, H., Horta-Barba, A., Pascual-Sedano, B., Santos-Garc\u00eda, D., de Deus-Fonticoba, T., Jes\u00fas, S., Aguilar, M., Planellas, L., Garc\u00eda-Caldentey, J., Caballol, N., Vives-Pastor, B., Hern\u00e1ndez-Vara, J., Cabo-Lopez, I., L\u00f3pez-Manzanares, L., Gonz\u00e1lez-Aramburu, I., \u00c1vila-Rivera, M. A., Catal\u00e1n, M. J., L\u00f3pez-D\u00edaz, L. M., \u2026 Kulisevsky, J. (2021). Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson\u2019s disease. BMC Neurology, 21(1), Article 477. https:\/\/doi.org\/10.1186\/s12883-021-02485-1","journal-title":"BMC Neurology"},{"issue":"8","key":"488_CR110","doi-asserted-by":"publisher","first-page":"5411","DOI":"10.1007\/s00415-024-12484-0","volume":"271","author":"A Ophey","year":"2024","unstructured":"Ophey, A., Wirtz, K., Wolfsgruber, S., Balzer-Geldsetzer, M., Berg, D., Hilker-Roggendorf, R., Kassubek, J., Liepelt-Scarfone, I., Becker, S., Mollenhauer, B., Reetz, K., Riedel, O., Schulz, J. B., Storch, A., Trenkwalder, C., Witt, K., Wittchen, H. U., Dodel, R., Roeske, S., & Kalbe, E. (2024). Mid- and late-life lifestyle activities as main drivers of general and domain-specific cognitive reserve in individuals with Parkinson\u2019s disease: Cross-sectional and longitudinal evidence from the LANDSCAPE study. Journal of Neurology, 271(8), 5411\u20135424. https:\/\/doi.org\/10.1007\/s00415-024-12484-0","journal-title":"Journal of Neurology"},{"issue":"5","key":"488_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100098","volume":"12","author":"GB Frisoni","year":"2025","unstructured":"Frisoni, G. B., Ribaldi, F., Allali, G., Bieth, T., Brioschi Guevara, A., Cappa, S., Cipolotti, L., Frederiksen, K. S., Georges, J., Jessen, F., Koch, G., Masters, H., Mendes, A. J., Fr\u00f6lich, L., Garibotto, V., Grau-Rivera, O., Pozzi, F. E., Religa, D., Rostamzadeh, A., \u2026 Kivipelto, M. (2025). Brain health services for the secondary prevention of cognitive impairment and dementia: Opportunities, challenges, and the business case for existing and future facilities. The Journal of Prevention of Alzheimer\u2019s Disease, 12(5), Article 100098. https:\/\/doi.org\/10.1016\/j.tjpad.2025.100098","journal-title":"The Journal of Prevention of Alzheimer's Disease"},{"key":"488_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100576","author":"GB Frisoni","year":"2023","unstructured":"Frisoni, G. B., Altomare, D., Ribaldi, F., Villain, N., Brayne, C., Mukadam, N., Abramowicz, M., Barkhof, F., Berthier, M., Bieler-Aeschlimann, M., Blennow, K., Guevara, A. B., Carrera, E., Ch\u00e9telat, G., Csajka, C., Demonet, J.-F., Dodich, A., Garibotto, V., Georges, J., \u2026 Dubois, B. (2023). Dementia prevention in memory clinics: Recommendations from the European task force for brain health services. The Lancet Regional Health - Europe. https:\/\/doi.org\/10.1016\/j.lanepe.2022.100576","journal-title":"The Lancet Regional Health - Europe"},{"issue":"8","key":"488_CR113","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1177\/1877718X251365769","volume":"15","author":"E Kalbe","year":"2025","unstructured":"Kalbe, E., Warnecke, T., Eggers, C., Ophey, A., & Folkerts, A.-K. (2025). Prevention of cognitive impairment and dementia in people with Parkinson\u2019s disease: A call-to-action. Journal of Parkinson\u2019s Disease, 15(8), 1353\u20131366. https:\/\/doi.org\/10.1177\/1877718X251365769","journal-title":"Journal of Parkinson's Disease"},{"issue":"1","key":"488_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/s42466-024-00325-4","volume":"6","author":"G H\u00f6glinger","year":"2024","unstructured":"H\u00f6glinger, G., & Trenkwalder, C. (2024). Diagnosis and treatment of Parkinson\u00b4s disease (guideline of the German Society for Neurology). Neurological Research and Practice, 6(1), Article 30. https:\/\/doi.org\/10.1186\/s42466-024-00325-4","journal-title":"Neurological Research and Practice"},{"issue":"11","key":"488_CR115","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1377\/hlthaff.2017.0832","volume":"36","author":"BR Bloem","year":"2017","unstructured":"Bloem, B. R., Rompen, L., Vries, N., Klink, A., Munneke, M., & Jeurissen, P. (2017). ParkinsonNet: A low-cost health care innovation with a systems approach from the Netherlands. Health Affairs, 36(11), 1987\u20131996. https:\/\/doi.org\/10.1377\/hlthaff.2017.0832","journal-title":"Health Affairs"},{"key":"488_CR116","unstructured":"Kognitive St\u00f6rungen bei der Parkinson-Krankheit: Zeit f\u00fcr Pr\u00e4vention?> | DGNeurologie. (n.d.). Retrieved January 7, (2026). from https:\/\/link.springer.com\/article\/10.1007\/s42451-025-00795-z"},{"key":"488_CR117","unstructured":"Schaeffer, E. (with University Hospital Schleswig-Holstein, University Hospital,Bonn, University of Cologne, Philipps University Marburg, & University of Kiel). (2025).PREVENTION-IN-PD - Development of a Multidomain Lifestyle Intervention Study for Prodromal and Clinical Parkinson\u2019s Disease (Clinical Trial Registration No. NCT07297407). clinicaltrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT07297407."},{"key":"488_CR118","unstructured":"Keus, S., Munneke, M., Graziano, M., Paltamaa, J., Pelosin, E., Domingos, J., Ramaswamy, B., Prins, J., Struiksma, C., Rochester, L., Nieuwboer, A., & Bloem, B. (2014). Europ\u00e4ische Physiotherapie-Leitlinie beim idiopathischen Parkinson-Syndrom."},{"issue":"10","key":"488_CR119","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1177\/1545968320952799","volume":"34","author":"DLM Radder","year":"2020","unstructured":"Radder, D. L. M., L\u00edgia Silva de Lima, A., Domingos, J., Keus, S. H. J., van Nimwegen, M., Bloem, B. R., & de Vries, N. M. (2020). Physiotherapy in Parkinson\u2019s disease: A meta-analysis of present treatment modalities. Neurorehabilitation and Neural Repair, 34(10), 871\u2013880. https:\/\/doi.org\/10.1177\/1545968320952799","journal-title":"Neurorehabilitation and Neural Repair"},{"issue":"6","key":"488_CR120","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1001\/jamaneurol.2019.0033","volume":"76","author":"J Nonnekes","year":"2019","unstructured":"Nonnekes, J., Ru\u017eicka, E., Nieuwboer, A., Hallett, M., Fasano, A., & Bloem, B. R. (2019). Compensation strategies for gait impairments in Parkinson disease: A review. JAMA Neurology, 76(6), 718\u2013725. https:\/\/doi.org\/10.1001\/jamaneurol.2019.0033","journal-title":"JAMA Neurology"},{"issue":"2","key":"488_CR121","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1474-4422(17)30406-4","volume":"17","author":"JHL Ypinga","year":"2018","unstructured":"Ypinga, J. H. L., de Vries, N. M., Boonen, L. H. H. M., Koolman, X., Munneke, M., Zwinderman, A. H., & Bloem, B. R. (2018). Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: A retrospective analysis of medical claims data. The Lancet. Neurology, 17(2), 153\u2013161. https:\/\/doi.org\/10.1016\/S1474-4422(17)30406-4","journal-title":"The Lancet. Neurology"},{"key":"488_CR122","unstructured":"Sturkenboom, I., Thijssen, M., Elsacker, J. G., Jansen, I., Maasdam, A., Schulten, M., Vijver-Visser, D., Steultjens, E., Bloem, B., & Munneke, M. (n.d.). Guidelines for Occupational Therapy in Parkinson\u2019s Disease Rehabilitation."},{"issue":"6","key":"488_CR123","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S1474-4422(14)70055-9","volume":"13","author":"IHWM Sturkenboom","year":"2014","unstructured":"Sturkenboom, I. H. W. M., Graff, M. J. L., Hendriks, J. C. M., Veenhuizen, Y., Munneke, M., Bloem, B. R., Nijhuis-van der Sanden, M. W., OTiP study group. (2014). Efficacy of occupational therapy for patients with Parkinson\u2019s disease: A randomised controlled trial. The Lancet Neurology, 13(6), 557\u2013566. https:\/\/doi.org\/10.1016\/S1474-4422(14)70055-9","journal-title":"The Lancet Neurology"},{"issue":"8","key":"488_CR124","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/mdc3.13089","volume":"7","author":"M Tofani","year":"2020","unstructured":"Tofani, M., Ranieri, A., Fabbrini, G., Berardi, A., Pelosin, E., Valente, D., Fabbrini, A., Costanzo, M., & Galeoto, G. (2020). Efficacy of occupational therapy interventions on quality of life in patients with Parkinson\u2019s disease: A systematic review and meta-analysis. Movement Disorders Clinical Practice, 7(8), 891\u2013901. https:\/\/doi.org\/10.1002\/mdc3.13089","journal-title":"Movement Disorders Clinical Practice"},{"key":"488_CR125","doi-asserted-by":"publisher","first-page":"S183","DOI":"10.1016\/S1353-8020(08)70916-7","volume":"13","author":"J Kalf","year":"2007","unstructured":"Kalf, J., De Swart, B., Bloem, B. R., & Munneke, M. (2007). 3.414 guidelines for speech\u2013language therapy in Parkinson\u2019s disease. Parkinsonism & Related Disorders, 13, S183\u2013S184. https:\/\/doi.org\/10.1016\/S1353-8020(08)70916-7","journal-title":"Parkinsonism & Related Disorders"},{"issue":"11","key":"488_CR126","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/mds.27460","volume":"33","author":"L Ramig","year":"2018","unstructured":"Ramig, L., Halpern, A., Spielman, J., Fox, C., & Freeman, K. (2018). Speech treatment in Parkinson\u2019s disease: Randomized controlled trial (RCT). Movement Disorders\u202f: Official Journal of the Movement Disorder Society, 33(11), 1777\u20131791. https:\/\/doi.org\/10.1002\/mds.27460","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"issue":"5","key":"488_CR127","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1177\/0269215520976267","volume":"35","author":"N Mu\u00f1oz-Vigueras","year":"2021","unstructured":"Mu\u00f1oz-Vigueras, N., Prados-Rom\u00e1n, E., Valenza, M. C., Granados-Santiago, M., Cabrera-Martos, I., Rodr\u00edguez-Torres, J., & Torres-S\u00e1nchez, I. (2021). Speech and language therapy treatment on hypokinetic dysarthria in Parkinson disease: Systematic review and meta-analysis. Clinical Rehabilitation, 35(5), 639\u2013655. https:\/\/doi.org\/10.1177\/0269215520976267","journal-title":"Clinical Rehabilitation"},{"key":"488_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.120008","volume":"430","author":"A Schindler","year":"2021","unstructured":"Schindler, A., Pizzorni, N., Cereda, E., Cosentino, G., Avenali, M., Montomoli, C., Abbruzzese, G., Antonini, A., Barbiera, F., Benazzo, M., Benarroch, E., Bertino, G., Clav\u00e8, P., Cortelli, P., Eleopra, R., Ferrari, C., Hamdy, S., Huckabee, M.-L., Lopiano, L., \u2026 Alfonsi, E. (2021). Consensus on the treatment of dysphagia in Parkinson\u2019s disease. Journal of the Neurological Sciences, 430, Article 120008. https:\/\/doi.org\/10.1016\/j.jns.2021.120008","journal-title":"Journal of the Neurological Sciences"},{"issue":"4","key":"488_CR129","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s00415-019-09657-7","volume":"267","author":"R Scherbaum","year":"2020","unstructured":"Scherbaum, R., Hartelt, E., Kinkel, M., Gold, R., Muhlack, S., & T\u00f6nges, L. (2020). Parkinson\u2019s disease multimodal complex treatment improves motor symptoms, depression and quality of life. Journal of Neurology, 267(4), 954\u2013965. https:\/\/doi.org\/10.1007\/s00415-019-09657-7","journal-title":"Journal of Neurology"},{"issue":"11","key":"488_CR130","doi-asserted-by":"publisher","first-page":"6067","DOI":"10.1007\/s00415-022-11257-x","volume":"269","author":"R Scherbaum","year":"2022","unstructured":"Scherbaum, R., Moewius, A., Oppermann, J., Geritz, J., Hansen, C., Gold, R., Maetzler, W., & T\u00f6nges, L. (2022). Parkinson\u2019s disease multimodal complex treatment improves gait performance: An exploratory wearable digital device-supported study. Journal of Neurology, 269(11), 6067\u20136085. https:\/\/doi.org\/10.1007\/s00415-022-11257-x","journal-title":"Journal of Neurology"},{"key":"488_CR131","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-025-02963-7","author":"R Scherbaum","year":"2025","unstructured":"Scherbaum, R., H\u00f6llerhage, M., Klebe, S., Riederer, P., M\u00fcller, T., Schr\u00f6ter, N., Weise, D., Woitalla, D., & T\u00f6nges, L. (2025). Parkinson\u2019s Disease Multidisciplinary Complex Therapy (PD-MCT): Appreciation of its current function for the treatment of people with Parkinson\u2019s disease in Germany and the needs of future development. Journal of Neural Transmission. https:\/\/doi.org\/10.1007\/s00702-025-02963-7","journal-title":"Journal of Neural Transmission"},{"issue":"2","key":"488_CR132","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1001\/jamaneurol.2017.3517","volume":"75","author":"M Schenkman","year":"2018","unstructured":"Schenkman, M., Moore, C. G., Kohrt, W. M., Hall, D. A., Delitto, A., Comella, C. L., Josbeno, D. A., Christiansen, C. L., Berman, B. D., Kluger, B. M., Melanson, E. L., Jain, S., Robichaud, J. A., Poon, C., & Corcos, D. M. (2018). Effect of high-intensity treadmill exercise on motor symptoms in patients with De novo Parkinson Disease: A phase 2 randomized clinical trial. JAMA Neurology, 75(2), 219\u2013226. https:\/\/doi.org\/10.1001\/jamaneurol.2017.3517","journal-title":"JAMA Neurology"},{"issue":"11","key":"488_CR133","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S1474-4422(19)30285-6","volume":"18","author":"NM van der Kolk","year":"2019","unstructured":"van der Kolk, N. M., de Vries, N. M., Kessels, R. P. C., Joosten, H., Zwinderman, A. H., Post, B., & Bloem, B. R. (2019). Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson\u2019s disease: A double-blind, randomised controlled trial. The Lancet. Neurology, 18(11), 998\u20131008. https:\/\/doi.org\/10.1016\/S1474-4422(19)30285-6","journal-title":"The Lancet. Neurology"},{"issue":"1","key":"488_CR134","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013856.pub2","volume":"1","author":"M Ernst","year":"2023","unstructured":"Ernst, M., Folkerts, A.-K., Gollan, R., Lieker, E., Caro-Valenzuela, J., Adams, A., Cryns, N., Monsef, I., Dresen, A., Roheger, M., Eggers, C., Skoetz, N., & Kalbe, E. (2023). Physical exercise for people with Parkinson\u2019s disease: A systematic review and network meta-analysis. The Cochrane Database of Systematic Reviews, 1(1), Article CD013856. https:\/\/doi.org\/10.1002\/14651858.CD013856.pub2","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"1","key":"488_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00418-4","volume":"8","author":"K Zhen","year":"2022","unstructured":"Zhen, K., Zhang, S., Tao, X., Li, G., Lv, Y., & Yu, L. (2022). A systematic review and meta-analysis on effects of aerobic exercise in people with Parkinson\u2019s disease. NPJ Parkinson\u2019s Disease, 8(1), Article 146. https:\/\/doi.org\/10.1038\/s41531-022-00418-4","journal-title":"NPJ Parkinson's Disease"},{"key":"488_CR136","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.935176","volume":"14","author":"X Zhou","year":"2022","unstructured":"Zhou, X., Zhao, P., Guo, X., Wang, J., & Wang, R. (2022). Effectiveness of aerobic and resistance training on the motor symptoms in Parkinson\u2019s disease: Systematic review and network meta-analysis. Frontiers in Aging Neuroscience, 14, Article 935176. https:\/\/doi.org\/10.3389\/fnagi.2022.935176","journal-title":"Frontiers in Aging Neuroscience"},{"key":"488_CR137","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1215495","volume":"15","author":"D Wang","year":"2023","unstructured":"Wang, D., Cui, W. J., Hou, Z. H., & Gao, Y. (2023). Effectiveness of different exercises in improving postural balance among Parkinson\u2019s disease patients: A systematic review and network meta-analysis. Frontiers in Aging Neuroscience, 15, Article 1215495. https:\/\/doi.org\/10.3389\/fnagi.2023.1215495","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"11","key":"488_CR138","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0293357","volume":"18","author":"IGD Sena","year":"2023","unstructured":"Sena, I. G. D., Costa, A., Santos, I. K. D., Ara\u00fajo, D., Gomes, F., Cavalcanti, J., Knackfuss, M. I., Andrade, M., Melo, P. K. M., & Fonseca, I. A. T. (2023). Feasibility and effect of high-intensity training on the progression of motor symptoms in adult individuals with Parkinson\u2019s disease: A systematic review and meta-analysis. PLoS One, 18(11), Article e0293357. https:\/\/doi.org\/10.1371\/journal.pone.0293357","journal-title":"PLoS One"},{"issue":"7","key":"488_CR139","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181515","volume":"12","author":"P-L Wu","year":"2017","unstructured":"Wu, P.-L., Lee, M., & Huang, T.-T. (2017). Effectiveness of physical activity on patients with depression and Parkinson\u2019s disease: A systematic review. PLoS One, 12(7), Article e0181515. https:\/\/doi.org\/10.1371\/journal.pone.0181515","journal-title":"PLoS One"},{"issue":"1","key":"488_CR140","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000527029","volume":"86","author":"X Yang","year":"2023","unstructured":"Yang, X., & Wang, Z. (2023). Effectiveness of progressive resistance training in Parkinson\u2019s disease: A systematic review and meta-analysis. European Neurology, 86(1), 25\u201333. https:\/\/doi.org\/10.1159\/000527029","journal-title":"European Neurology"},{"issue":"5","key":"488_CR141","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/mds.21922","volume":"23","author":"VA Goodwin","year":"2008","unstructured":"Goodwin, V. A., Richards, S. H., Taylor, R. S., Taylor, A. H., & Campbell, J. L. (2008). The effectiveness of exercise interventions for people with Parkinson\u2019s disease: A systematic review and meta-analysis. Movement Disorders\u202f: Official Journal of the Movement Disorder Society, 23(5), 631\u2013640. https:\/\/doi.org\/10.1002\/mds.21922","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"issue":"5","key":"488_CR142","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/ane.13579","volume":"145","author":"M Gamborg","year":"2022","unstructured":"Gamborg, M., Hvid, L. G., Dalgas, U., & Langeskov-Christensen, M. (2022). Parkinson\u2019s disease and intensive exercise therapy\u2014An updated systematic review and meta-analysis. Acta Neurologica Scandinavica, 145(5), 504\u2013528. https:\/\/doi.org\/10.1111\/ane.13579","journal-title":"Acta Neurologica Scandinavica"},{"issue":"9","key":"488_CR143","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s00702-022-02514-4","volume":"129","author":"H Ga\u00dfner","year":"2022","unstructured":"Ga\u00dfner, H., Trutt, E., Seifferth, S., Friedrich, J., Zucker, D., Salhani, Z., Adler, W., Winkler, J., & Jost, W. H. (2022). Treadmill training and physiotherapy similarly improve dual task gait performance: A randomized-controlled trial in Parkinson\u2019s disease. Journal of Neural Transmission, 129(9), 1189\u20131200. https:\/\/doi.org\/10.1007\/s00702-022-02514-4","journal-title":"Journal of Neural Transmission"},{"issue":"2","key":"488_CR144","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/1545968314542981","volume":"29","author":"G Frazzitta","year":"2015","unstructured":"Frazzitta, G., Maestri, R., Bertotti, G., Riboldazzi, G., Boveri, N., Perini, M., Uccellini, D., Turla, M., Comi, C., Pezzoli, G., & Ghilardi, M. F. (2015). Intensive rehabilitation treatment in early Parkinson\u2019s disease: A randomized pilot study with a 2-year follow-up. Neurorehabilitation and Neural Repair, 29(2), 123\u2013131. https:\/\/doi.org\/10.1177\/1545968314542981","journal-title":"Neurorehabilitation and Neural Repair"},{"key":"488_CR145","doi-asserted-by":"publisher","unstructured":"Dm, C., Ja, R., Fj, D., Se, L., De, V., Mr, C. P., Wm, R., K., & Cl, C. (2013). A two-year randomized controlled trial of progressive resistance exercise for Parkinson\u2019s disease. Movement Disorders : Official Journal of the Movement Disorder Society, 28(9). https:\/\/doi.org\/10.1002\/mds.25380","DOI":"10.1002\/mds.25380"},{"issue":"1","key":"488_CR146","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-021-02656-2","volume":"22","author":"JS Pigott","year":"2022","unstructured":"Pigott, J. S., Kane, E. J., Ambler, G., Walters, K., & Schrag, A. (2022). Systematic review and meta-analysis of clinical effectiveness of self-management interventions in Parkinson\u2019s disease. BMC Geriatrics, 22(1), Article 45. https:\/\/doi.org\/10.1186\/s12877-021-02656-2","journal-title":"BMC Geriatrics"},{"issue":"7","key":"488_CR147","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1111\/jocn.17136","volume":"33","author":"X Gao","year":"2024","unstructured":"Gao, X., Zhang, H., Fu, X., Yang, Y., & Dou, J. (2024). The effect of home-based exercise on motor and non-motor symptoms with Parkinson\u2019s disease patients: A systematic review and network meta-analysis. Journal of Clinical Nursing, 33(7), 2755\u20132774. https:\/\/doi.org\/10.1111\/jocn.17136","journal-title":"Journal of Clinical Nursing"},{"issue":"8","key":"488_CR148","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1212\/WNL.0000000000013218","volume":"98","author":"K Tsukita","year":"2022","unstructured":"Tsukita, K., Sakamaki-Tsukita, H., & Takahashi, R. (2022). Long-term effect of regular physical activity and exercise habits in patients with early Parkinson disease. Neurology, 98(8), e859\u2013e871. https:\/\/doi.org\/10.1212\/WNL.0000000000013218","journal-title":"Neurology"},{"issue":"1","key":"488_CR149","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3233\/JPD-160912","volume":"7","author":"MR Rafferty","year":"2017","unstructured":"Rafferty, M. R., Schmidt, P. N., Luo, S. T., Li, K., Marras, C., Davis, T. L., Guttman, M., Cubillos, F., & Simuni, T. (2017). Regular exercise, quality of life, and mobility in Parkinson\u2019s disease: A longitudinal analysis of National Parkinson Foundation Quality Improvement Initiative Data. Journal of Parkinson\u2019s Disease, 7(1), 193\u2013202. https:\/\/doi.org\/10.3233\/JPD-160912","journal-title":"Journal of Parkinson's Disease"},{"issue":"4","key":"488_CR150","doi-asserted-by":"publisher","first-page":"548","DOI":"10.11124\/JBISRIR-2017-003901","volume":"17","author":"H Hunter","year":"2019","unstructured":"Hunter, H., Lovegrove, C., Haas, B., Freeman, J., & Gunn, H. (2019). Experiences of people with Parkinson\u2019s disease and their views on physical activity interventions: A qualitative systematic review. JBI Database of Systematic Reviews and Implementation Reports, 17(4), 548\u2013613. https:\/\/doi.org\/10.11124\/JBISRIR-2017-003901","journal-title":"JBI Database of Systematic Reviews and Implementation Reports"},{"key":"488_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2020.102366","volume":"50","author":"Z Paknahad","year":"2020","unstructured":"Paknahad, Z., Sheklabadi, E., Derakhshan, Y., Bagherniya, M., & Chitsaz, A. (2020). The effect of the Mediterranean diet on cognitive function in patients with Parkinson\u2019s disease: A randomized clinical controlled trial. Complementary Therapies in Medicine, 50, Article 102366. https:\/\/doi.org\/10.1016\/j.ctim.2020.102366","journal-title":"Complementary Therapies in Medicine"},{"issue":"2","key":"488_CR152","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/1028415X.2020.1751509","volume":"25","author":"Z Paknahad","year":"2022","unstructured":"Paknahad, Z., Sheklabadi, E., Moravejolahkami, A. R., Chitsaz, A., & Hassanzadeh, A. (2022). The effects of Mediterranean diet on severity of disease and serum Total Antioxidant Capacity (TAC) in patients with Parkinson\u2019s disease: A single center, randomized controlled trial. Nutritional Neuroscience, 25(2), 313\u2013320. https:\/\/doi.org\/10.1080\/1028415X.2020.1751509","journal-title":"Nutritional Neuroscience"},{"key":"488_CR153","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.794640","volume":"12","author":"C Rusch","year":"2021","unstructured":"Rusch, C., Beke, M., Tucciarone, L., Nieves, C., Ukhanova, M., Tagliamonte, M. S., Mai, V., Suh, J. H., Wang, Y., Chiu, S., Patel, B., Ramirez-Zamora, A., & Langkamp-Henken, B. (2021). Mediterranean diet adherence in people with Parkinson\u2019s disease reduces constipation symptoms and changes fecal microbiota after a 5-week single-arm pilot study. Frontiers in Neurology, 12, Article 794640. https:\/\/doi.org\/10.3389\/fneur.2021.794640","journal-title":"Frontiers in Neurology"},{"issue":"1","key":"488_CR154","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-01100-1","volume":"11","author":"H Cao","year":"2025","unstructured":"Cao, H., Zhao, Y., Chen, Z., Zou, X., Du, X., Yi, L., Ai, Y., Zuo, H., & Cheng, O. (2025). Triglyceride-glucose index predicts cognitive decline and striatal dopamine deficiency in Parkinson disease in two cohorts. NPJ Parkinson\u2019s Disease, 11(1), Article 240. https:\/\/doi.org\/10.1038\/s41531-025-01100-1","journal-title":"NPJ Parkinson's Disease"},{"issue":"8","key":"488_CR155","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1002\/mds.29122","volume":"37","author":"D Athauda","year":"2022","unstructured":"Athauda, D., Evans, J., Wernick, A., Virdi, G., Choi, M. L., Lawton, M., Vijiaratnam, N., Girges, C., Ben-Shlomo, Y., Ismail, K., Morris, H., Grosset, D., Foltynie, T., & Gandhi, S. (2022). The impact of type 2 diabetes in Parkinson\u2019s disease. Movement Disorders\u202f: Official Journal of the Movement Disorder Society, 37(8), 1612\u20131623. https:\/\/doi.org\/10.1002\/mds.29122","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"key":"488_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1109914","volume":"15","author":"Q Zhong","year":"2023","unstructured":"Zhong, Q., & Wang, S. (2023). Association between diabetes mellitus, prediabetes and risk, disease progression of Parkinson\u2019s disease: A systematic review and meta-analysis. Frontiers in Aging Neuroscience, 15, Article 1109914. https:\/\/doi.org\/10.3389\/fnagi.2023.1109914","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"6","key":"488_CR157","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/mds.28551","volume":"36","author":"H Chohan","year":"2021","unstructured":"Chohan, H., Senkevich, K., Patel, R. K., Bestwick, J. P., Jacobs, B. M., Bandres Ciga, S., Gan-Or, Z., & Noyce, A. J. (2021). Type 2 diabetes as a determinant of Parkinson\u2019s disease risk and progression. Movement Disorders\u202f: Official Journal of the Movement Disorder Society, 36(6), 1420\u20131429. https:\/\/doi.org\/10.1002\/mds.28551","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"key":"488_CR158","doi-asserted-by":"publisher","unstructured":"Lopes, D. M., Llewellyn, S. K., Bury, S. E., Wang, J., Wells, J. A., Gegg, M. E., Verona, G., Lythgoe, M. F., & Harrison, I. F. (2025). The influence of the glymphatic system on \u03b1-synuclein propagation: The role of aquaporin-4. Brain, awaf255. https:\/\/doi.org\/10.1093\/brain\/awaf255","DOI":"10.1093\/brain\/awaf255"},{"issue":"4","key":"488_CR159","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/ana.26729","volume":"94","author":"P He","year":"2023","unstructured":"He, P., Shi, L., Li, Y., Duan, Q., Qiu, Y., Feng, S., Gao, Y., Luo, Y., Ma, G., Zhang, Y., Wang, L., & Nie, K. (2023). The association of the glymphatic function with Parkinson\u2019s disease symptoms: Neuroimaging evidence from longitudinal and cross-sectional studies. Annals of Neurology, 94(4), 672\u2013683. https:\/\/doi.org\/10.1002\/ana.26729","journal-title":"Annals of Neurology"},{"issue":"1","key":"488_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-00921-4","volume":"11","author":"S Marecek","year":"2025","unstructured":"Marecek, S., Rottova, V., Nepozitek, J., Krajca, T., Krupicka, R., Keller, J., Zogala, D., Trnka, J., Sonka, K., Ruzicka, E., & Dusek, P. (2025). Exploring glymphatic system alterations in iRBD and Parkinson\u2019s disease using automated DTI-ALPS analysis. NPJ Parkinson\u2019s Disease, 11(1), Article 76. https:\/\/doi.org\/10.1038\/s41531-025-00921-4","journal-title":"NPJ Parkinson's Disease"},{"key":"488_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105767","volume":"114","author":"YJ Bae","year":"2023","unstructured":"Bae, Y. J., Kim, J.-M., Choi, B. S., Choi, J.-H., Ryoo, N., Song, Y. S., Cho, S. J., & Kim, J. H. (2023). Glymphatic function assessment in Parkinson\u2019s disease using diffusion tensor image analysis along the perivascular space. Parkinsonism & Related Disorders, 114, Article 105767. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105767","journal-title":"Parkinsonism & Related Disorders"},{"key":"488_CR162","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1628697","author":"Y Gao","year":"2025","unstructured":"Gao, Y., Li, Y., Ji, N., Meng, P., Hu, Q., Chen, Y., Guan, X., & Xu, B. (2025). Predictive value of the combined DTI-ALPS index and serum creatinine levels in mild cognitive impairment in Parkinson\u2019s disease. Frontiers in Neurology. https:\/\/doi.org\/10.3389\/fneur.2025.1628697","journal-title":"Frontiers in Neurology"},{"issue":"3","key":"488_CR163","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s00415-025-12944-1","volume":"272","author":"J Ren","year":"2025","unstructured":"Ren, J., Xie, D., Wang, L., Wu, Z., Lin, S., Jin, Q., Luo, Y., Zhu, B., Huang, H., Wang, J., Zhang, S., Liu, Z., Chen, G., Luo, M., & Yang, D. (2025). Glymphatic system dysfunction as a biomarker of disease progression in Parkinson\u2019s disease: Neuroimaging evidence from longitudinal cohort studies. Journal of Neurology, 272(3), 196. https:\/\/doi.org\/10.1007\/s00415-025-12944-1","journal-title":"Journal of Neurology"},{"issue":"3","key":"488_CR164","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/mds.28412","volume":"36","author":"M Elfil","year":"2021","unstructured":"Elfil, M., Bahbah, E. I., Attia, M. M., Eldokmak, M., & Koo, B. B. (2021). Impact of obstructive sleep apnea on cognitive and motor functions in Parkinson\u2019s disease. Movement Disorders, 36(3), 570\u2013580. https:\/\/doi.org\/10.1002\/mds.28412","journal-title":"Movement Disorders"},{"issue":"5","key":"488_CR165","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/ana.25459","volume":"85","author":"SJ Schreiner","year":"2019","unstructured":"Schreiner, S. J., Imbach, L. L., Werth, E., Poryazova, R., Baumann-Vogel, H., Valko, P. O., Murer, T., Noain, D., & Baumann, C. R. (2019). Slow-wave sleep and motor progression in Parkinson disease. Annals of Neurology, 85(5), 765\u2013770. https:\/\/doi.org\/10.1002\/ana.25459","journal-title":"Annals of Neurology"},{"issue":"12","key":"488_CR166","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003633.pub3","volume":"12","author":"M Castel\u00e3o","year":"2017","unstructured":"Castel\u00e3o, M., Marques, R. E., Duarte, G. S., Rodrigues, F. B., Ferreira, J., Sampaio, C., Moore, A. P., & Costa, J. (2017). Botulinum toxin type A therapy for cervical dystonia. Cochrane Database of Systematic Reviews, 12(12), Article CD003633. https:\/\/doi.org\/10.1002\/14651858.CD003633.pub3","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"488_CR167","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/dmcn.14874","volume":"63","author":"E Bohn","year":"2021","unstructured":"Bohn, E., Goren, K., Switzer, L., Falck-Ytter, Y., & Fehlings, D. (2021). Pharmacological and neurosurgical interventions for individuals with cerebral palsy and dystonia: A systematic review update and meta-analysis. Developmental Medicine and Child Neurology, 63(9), 1038\u20131050. https:\/\/doi.org\/10.1111\/dmcn.14874","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"6","key":"488_CR168","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1468-1331.2004.00845.x","volume":"11","author":"Y Balash","year":"2004","unstructured":"Balash, Y., & Giladi, N. (2004). Efficacy of pharmacological treatment of dystonia: Evidence-based review including meta-analysis of the effect of botulinum toxin and other cure options. European Journal of Neurology, 11(6), 361\u2013370. https:\/\/doi.org\/10.1111\/j.1468-1331.2004.00845.x","journal-title":"European Journal of Neurology"},{"issue":"1","key":"488_CR169","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/dmcn.14063","volume":"61","author":"LM Elkaim","year":"2019","unstructured":"Elkaim, L. M., Alotaibi, N. M., Sigal, A., Alotaibi, H. M., Lipsman, N., Kalia, S. K., Fehlings, D. L., Lozano, A. M., Ibrahim, G. M., North American Pediatric DBS Collaboration. (2019). Deep brain stimulation for pediatric dystonia: A meta-analysis with individual participant data. Developmental Medicine and Child Neurology, 61(1), 49\u201356. https:\/\/doi.org\/10.1111\/dmcn.14063","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"8","key":"488_CR170","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/papr.12408","volume":"16","author":"PD Charles","year":"2016","unstructured":"Charles, P. D., Manack Adams, A., Davis, T., Bradley, K., Schwartz, M., Brin, M. F., & Patel, A. T. (2016). Neck pain and cervical dystonia: Treatment outcomes from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy). Pain Practice, 16(8), 1073\u20131082. https:\/\/doi.org\/10.1111\/papr.12408","journal-title":"Pain Practice"},{"issue":"3","key":"488_CR171","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1136\/jnnp.74.3.305","volume":"74","author":"JA Fields","year":"2003","unstructured":"Fields, J. A., Tr\u00f6ster, A. I., Woods, S. P., Higginson, C. I., Wilkinson, S. B., Lyons, K. E., Koller, W. C., & Pahwa, R. (2003). Neuropsychological and quality of life outcomes 12 months after unilateral thalamic stimulation for essential tremor. Journal of Neurology, Neurosurgery, and Psychiatry, 74(3), 305\u2013311. https:\/\/doi.org\/10.1136\/jnnp.74.3.305","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"3","key":"488_CR172","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000529418","volume":"101","author":"R Gupta","year":"2023","unstructured":"Gupta, R., Paulo, D., Sun, L., Ye, F., Dhima, K., & Bick, S. K. (2023). Depression scores following ventral intermediate nucleus deep brain stimulation for essential tremor: A meta-analysis. Stereotactic and Functional Neurosurgery, 101(3), 170\u2013178. https:\/\/doi.org\/10.1159\/000529418","journal-title":"Stereotactic and Functional Neurosurgery"},{"issue":"4","key":"488_CR173","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ymgme.2015.01.014","volume":"114","author":"G Helman","year":"2015","unstructured":"Helman, G., Van Haren, K., Bonkowsky, J. L., Bernard, G., Pizzino, A., Braverman, N., Suhr, D., Patterson, M. C., Ali Fatemi, S., Leonard, J., van der Knaap, M. S., Back, S. A., Damiani, S., Goldman, S. A., Takanohashi, A., Petryniak, M., Rowitch, D., Messing, A., Wrabetz, L., GLIA Consortium. (2015). Disease specific therapies in leukodystrophies and leukoencephalopathies. Molecular Genetics and Metabolism, 114(4), 527\u2013536. https:\/\/doi.org\/10.1016\/j.ymgme.2015.01.014","journal-title":"Molecular Genetics and Metabolism"},{"key":"488_CR174","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejpn.2025.03.016","volume":"56","author":"NI Wolf","year":"2025","unstructured":"Wolf, N. I., van der Knaap, M. S., & Engelen, M. (2025). Treatment of leukodystrophies: Advances and challenges. European Journal of Paediatric Neurology, 56, 46\u201350. https:\/\/doi.org\/10.1016\/j.ejpn.2025.03.016","journal-title":"European Journal of Paediatric Neurology"},{"issue":"20","key":"488_CR175","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1056\/NEJMoa042604","volume":"352","author":"ML Escolar","year":"2005","unstructured":"Escolar, M. L., Poe, M. D., Provenzale, J. M., Richards, K. C., Allison, J., Wood, S., Wenger, D. A., Pietryga, D., Wall, D., Champagne, M., Morse, R., Krivit, W., & Kurtzberg, J. (2005). Transplantation of umbilical-cord blood in babies with infantile Krabbe\u2019s disease. The New England Journal of Medicine, 352(20), 2069\u20132081. https:\/\/doi.org\/10.1056\/NEJMoa042604","journal-title":"The New England Journal of Medicine"},{"issue":"11","key":"488_CR176","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15112522","volume":"15","author":"F Aerts-Kaya","year":"2023","unstructured":"Aerts-Kaya, F., & van Til, N. P. (2023). Gene and cellular therapies for leukodystrophies. Pharmaceutics, 15(11), Article 2522. https:\/\/doi.org\/10.3390\/pharmaceutics15112522","journal-title":"Pharmaceutics"},{"key":"488_CR177","doi-asserted-by":"publisher","DOI":"10.1002\/mds.30067","author":"K Atterling Brolin","year":"2024","unstructured":"Atterling Brolin, K., Schaeffer, E., Kuri, A., Rumrich, I. K., Schumacher Schuh, A. F., Darweesh, S. K. L., Kaasinen, V., Tolppanen, A.-M., Chahine, L. M., & Noyce, A. J. (2024). Environmental risk factors for Parkinson\u2019s disease: A critical review and policy implications. Movement Disorders. https:\/\/doi.org\/10.1002\/mds.30067","journal-title":"Movement Disorders"},{"key":"488_CR178","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101671","volume":"80","author":"HM Gavelin","year":"2022","unstructured":"Gavelin, H. M., Domell\u00f6f, M. E., Leung, I., Neely, A. S., Launder, N. H., Nategh, L., Finke, C., & Lampit, A. (2022). Computerized cognitive training in Parkinson\u2019s disease: A systematic review and meta-analysis. Ageing Research Reviews, 80, Article 101671. https:\/\/doi.org\/10.1016\/j.arr.2022.101671","journal-title":"Ageing Research Reviews"},{"issue":"1","key":"488_CR179","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3109\/02770909009073289","volume":"27","author":"RC Ahrens","year":"1990","unstructured":"Ahrens, R. C. (1990). Skeletal muscle tremor and the influence of adrenergic drugs. Journal of Asthma, 27(1), 11\u201320. https:\/\/doi.org\/10.3109\/02770909009073289","journal-title":"Journal of Asthma"},{"key":"488_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120192","author":"JF Baizabal-Carvallo","year":"2022","unstructured":"Baizabal-Carvallo, J. F., & Morgan, J. C. (2022). Drug-induced tremor, clinical features, diagnostic approach and management. Journal of the Neurological Sciences. https:\/\/doi.org\/10.1016\/j.jns.2022.120192","journal-title":"Journal of the Neurological Sciences"},{"issue":"12","key":"488_CR181","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S1474-4422(05)70250-7","volume":"4","author":"JC Morgan","year":"2005","unstructured":"Morgan, J. C., & Sethi, K. D. (2005). Drug-induced tremors. The Lancet Neurology, 4(12), 866\u2013876. https:\/\/doi.org\/10.1016\/S1474-4422(05)70250-7","journal-title":"The Lancet Neurology"},{"issue":"3","key":"488_CR182","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/mdc3.13656","volume":"10","author":"SA Schneider","year":"2023","unstructured":"Schneider, S. A., Tschaidse, L., & Reisch, N. (2023). Thyroid disorders and movement disorders-a systematic review. Movement Disorders Clinical Practice, 10(3), 360\u2013368. https:\/\/doi.org\/10.1002\/mdc3.13656","journal-title":"Movement Disorders Clinical Practice"},{"issue":"7","key":"488_CR183","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.parkreldis.2010.12.016","volume":"17","author":"RJ O\u2019Connor","year":"2011","unstructured":"O\u2019Connor, R. J., & Kini, M. U. (2011). Non-pharmacological and non-surgical interventions for tremor: A systematic review. Parkinsonism & Related Disorders, 17(7), 509\u2013515. https:\/\/doi.org\/10.1016\/j.parkreldis.2010.12.016","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"488_CR184","doi-asserted-by":"publisher","first-page":"303","DOI":"10.5604\/20831862.1127343","volume":"31","author":"A Tomczak","year":"2014","unstructured":"Tomczak, A., Gajewski, J., & Mazur-R\u00f3\u017cycka, J. (2014). Changes in physiological tremor resulting from sleep deprivation under conditions of increasing fatigue during prolonged military training. Biology of Sport, 31(4), 303\u2013308. https:\/\/doi.org\/10.5604\/20831862.1127343","journal-title":"Biology of Sport"},{"issue":"5","key":"488_CR185","first-page":"295","volume":"40","author":"W Growdon","year":"2000","unstructured":"Growdon, W., Ghika, J., Henderson, J., van Melle, G., Regli, F., Bogousslavsky, J., & Growdon, J. H. (2000). Effects of proximal and distal muscles\u2019 groups contraction and mental stress on the amplitude and frequency of physiological finger tremor. An accelerometric study. Electromyography and Clinical Neurophysiology, 40(5), 295\u2013303.","journal-title":"Electromyography and Clinical Neurophysiology"},{"key":"488_CR186","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-025-03026-7","author":"G Paparella","year":"2025","unstructured":"Paparella, G., Panfili, M., Akgun, S., Angelini, L., Martini, A., Grandolfo, A. S., De Riggi, M., Costa, D., Birreci, D., Maraone, A., Bersani, F. S., & Bologna, M. (2025). Neuropsychiatric, stress-related symptoms and essential tremor clinical variability. Journal of Neural Transmission. https:\/\/doi.org\/10.1007\/s00702-025-03026-7","journal-title":"Journal of Neural Transmission"},{"key":"488_CR187","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120197","volume":"435","author":"R Bhidayasiri","year":"2022","unstructured":"Bhidayasiri, R., Maytharakcheep, S., Phumphid, S., & Maetzler, W. (2022). Improving functional disability in patients with tremor: A clinical perspective of the efficacies, considerations, and challenges of assistive technology. Journal of the Neurological Sciences, 435, Article 120197. https:\/\/doi.org\/10.1016\/j.jns.2022.120197","journal-title":"Journal of the Neurological Sciences"},{"key":"488_CR188","doi-asserted-by":"publisher","unstructured":"Castrillo-Fraile, V., Pe\u00f1a, E. C., Gal\u00e1n, J. M. T. G., y, Delgado-L\u00f3pez, P. D., Collazo, C., & Cubo, E. (2019). Tremor Control Devices for Essential Tremor: A Systematic Literature Review. Tremor and Other Hyperkinetic Movements, 9(0). https:\/\/doi.org\/10.5334\/tohm.511","DOI":"10.5334\/tohm.511"},{"issue":"3","key":"488_CR189","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.psc.2016.04.003","volume":"39","author":"SN Caroff","year":"2016","unstructured":"Caroff, S. N., & Campbell, E. C. (2016). Drug-induced extrapyramidal syndromes: Implications for contemporary practice. The Psychiatric Clinics of North America, 39(3), 391\u2013411. https:\/\/doi.org\/10.1016\/j.psc.2016.04.003","journal-title":"The Psychiatric Clinics of North America"},{"issue":"3","key":"488_CR190","doi-asserted-by":"publisher","first-page":"195","DOI":"10.14712\/23362936.2024.19","volume":"125","author":"VV Byroju","year":"2024","unstructured":"Byroju, V. V., Rissardo, J. P., Durante, \u00cd., & Caprara, A. L. F. (2024). Cocaine-induced movement disorder: A literature review. Prague Medical Report, 125(3), 195\u2013219. https:\/\/doi.org\/10.14712\/23362936.2024.19","journal-title":"Prague Medical Report"},{"issue":"9","key":"488_CR191","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/jnnp-2015-311298","volume":"87","author":"A Sadnicka","year":"2016","unstructured":"Sadnicka, A., Kassavetis, P., Pare\u00e9s, I., Meppelink, A. M., Butler, K., & Edwards, M. (2016). Task-specific dystonia: Pathophysiology and management. Journal of Neurology, Neurosurgery, and Psychiatry, 87(9), 968\u2013974. https:\/\/doi.org\/10.1136\/jnnp-2015-311298","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"7","key":"488_CR192","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1136\/jnnp-2014-309106","volume":"86","author":"ME van Egmond","year":"2015","unstructured":"van Egmond, M. E., Kuiper, A., Eggink, H., Sinke, R. J., Brouwer, O. F., Verschuuren-Bemelmans, C. C., Sival, D. A., Tijssen, M. A. J., & de Koning, T. J. (2015). Dystonia in children and adolescents: A systematic review and a new diagnostic algorithm. Journal of Neurology, Neurosurgery, and Psychiatry, 86(7), 774\u2013781. https:\/\/doi.org\/10.1136\/jnnp-2014-309106","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"9","key":"488_CR193","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/jnnp-2015-311298","volume":"87","author":"A Sadnicka","year":"2016","unstructured":"Sadnicka, A., Kassavetis, P., Pare\u00e9s, I., Meppelink, A. M., Butler, K., & Edwards, M. (2016). Task-specific dystonia: Pathophysiology and management. Journal of Neurology, Neurosurgery & Psychiatry, 87(9), 968\u2013974. https:\/\/doi.org\/10.1136\/jnnp-2015-311298","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"2","key":"488_CR194","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/mds.28874","volume":"37","author":"A Weissbach","year":"2022","unstructured":"Weissbach, A., Pauly, M. G., Herzog, R., Hahn, L., Halmans, S., Hamami, F., Bolte, C., Camargos, S., Jeon, B., Kurian, M. A., Opladen, T., Br\u00fcggemann, N., Huppertz, H.-J., K\u00f6nig, I. R., Klein, C., & Lohmann, K. (2022). Relationship of genotype, phenotype, and treatment in dopa-responsive dystonia: MDSGene review. Movement Disorders, 37(2), 237\u2013252. https:\/\/doi.org\/10.1002\/mds.28874","journal-title":"Movement Disorders"},{"issue":"7","key":"488_CR195","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073571","volume":"25","author":"J Koptielow","year":"2024","unstructured":"Koptielow, J., Szy\u0142ak, E., Szewczyk-Roszczenko, O., Roszczenko, P., Kochanowicz, J., Ku\u0142akowska, A., & Chor\u0105\u017cy, M. (2024). Genetic update and treatment for dystonia. International Journal of Molecular Sciences, 25(7), Article 3571. https:\/\/doi.org\/10.3390\/ijms25073571","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"488_CR196","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/jnnp-2021-328120","volume":"93","author":"ME van Egmond","year":"2022","unstructured":"van Egmond, M. E., Lagrand, T. J., Lizaitiene, G., Smit, M., & Tijssen, M. A. J. (2022). A novel diagnostic approach for patients with adult-onset dystonia. Journal of Neurology, Neurosurgery, and Psychiatry, 93(10), 1039\u20131048. https:\/\/doi.org\/10.1136\/jnnp-2021-328120","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"1","key":"488_CR197","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-023-03473-3","volume":"24","author":"SG Kassaye","year":"2024","unstructured":"Kassaye, S. G., De Hertogh, W., Crosiers, D., Gudina, E. K., & De Pauw, J. (2024). The effectiveness of physiotherapy for patients with isolated cervical dystonia: An updated systematic review and meta-analysis. BMC Neurology, 24(1), Article 53. https:\/\/doi.org\/10.1186\/s12883-023-03473-3","journal-title":"BMC Neurology"},{"issue":"11","key":"488_CR198","doi-asserted-by":"publisher","DOI":"10.3390\/toxins14110784","volume":"14","author":"D Loudovici-Krug","year":"2022","unstructured":"Loudovici-Krug, D., Derlien, S., Best, N., & G\u00fcnther, A. (2022). Physiotherapy for cervical dystonia: A systematic review of randomised controlled trials. Toxins, 14(11), Article 784. https:\/\/doi.org\/10.3390\/toxins14110784","journal-title":"Toxins"},{"issue":"10","key":"488_CR199","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s00415-013-7220-8","volume":"261","author":"J De Pauw","year":"2014","unstructured":"De Pauw, J., Van der Velden, K., Meirte, J., Van Daele, U., Truijen, S., Cras, P., Mercelis, R., & De Hertogh, W. (2014). The effectiveness of physiotherapy for cervical dystonia: A systematic literature review. Journal of Neurology, 261(10), 1857\u20131865. https:\/\/doi.org\/10.1007\/s00415-013-7220-8","journal-title":"Journal of Neurology"},{"issue":"8","key":"488_CR200","doi-asserted-by":"publisher","first-page":"269","DOI":"10.33588\/rn.7208.2020421","volume":"72","author":"R Chiaramonte","year":"2021","unstructured":"Chiaramonte, R., & Vecchio, M. (2021). Rehabilitation of focal hand dystonia in musicians: A systematic review of the studies. Revista de neurolog\u00eda, 72(8), 269\u2013282. https:\/\/doi.org\/10.33588\/rn.7208.2020421","journal-title":"Revista de neurolog\u00eda"},{"key":"488_CR201","volume":"2014","author":"A Snaith","year":"2014","unstructured":"Snaith, A., & Wade, D. (2014). Dystonia. BMJ Clinical Evidence, 2014, Article 1211.","journal-title":"BMJ Clinical Evidence"},{"issue":"11","key":"488_CR202","doi-asserted-by":"publisher","first-page":"e1551","DOI":"10.1212\/WNL.0000000000011596","volume":"96","author":"A Worthley","year":"2021","unstructured":"Worthley, A., & Simonyan, K. (2021). Suicidal ideations and attempts in patients with isolated dystonia. Neurology, 96(11), e1551\u2013e1560. https:\/\/doi.org\/10.1212\/WNL.0000000000011596","journal-title":"Neurology"},{"key":"488_CR203","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2023.1089333","author":"SC Andrews","year":"2023","unstructured":"Andrews, S. C., K\u00e4mpf, L., Curtin, D., Hinder, M., Wenderoth, N., Stout, J. C., & Coxon, J. P. (2023). A single bout of moderate-intensity aerobic exercise improves motor learning in premanifest and early Huntington\u2019s disease. Frontiers in Psychology. https:\/\/doi.org\/10.3389\/fpsyg.2023.1089333","journal-title":"Frontiers in Psychology"},{"key":"488_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117022","volume":"416","author":"DM Bartlett","year":"2020","unstructured":"Bartlett, D. M., Govus, A., Rankin, T., Lampit, A., Feindel, K., Poudel, G., Teo, W.-P., Lo, J., Georgiou-Karistianis, N., Ziman, M. R., & Cruickshank, T. M. (2020). The effects of multidisciplinary rehabilitation on neuroimaging, biological, cognitive and motor outcomes in individuals with premanifest Huntington\u2019s disease. Journal of the Neurological Sciences, 416, Article 117022. https:\/\/doi.org\/10.1016\/j.jns.2020.117022","journal-title":"Journal of the Neurological Sciences"},{"key":"488_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.107080","volume":"127","author":"H Wang","year":"2024","unstructured":"Wang, H., Dai, Y., Tai, Y., Zhou, Z., Zhou, X., Li, B., & Yu, L. (2024). Causal associations of physical activity and leisure sedentary behaviors with age at onset of Huntington\u2019s disease: A mendelian randomization study. Parkinsonism & Related Disorders, 127, Article 107080. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.107080","journal-title":"Parkinsonism & Related Disorders"},{"issue":"11","key":"488_CR206","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1002\/mds.29972","volume":"39","author":"K Huynh","year":"2024","unstructured":"Huynh, K., Georgiou-Karistianis, N., Lampit, A., Siddiqui, M. N., Stout, J. C., & Jamadar, S. D. (2024). Computerized cognitive training increases gray matter volumes in Huntington\u2019s Disease: A pilot study. Movement Disorders, 39(11), 2119\u20132121. https:\/\/doi.org\/10.1002\/mds.29972","journal-title":"Movement Disorders"},{"issue":"5","key":"488_CR207","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1212\/WNL.0000000000008887","volume":"94","author":"L Quinn","year":"2020","unstructured":"Quinn, L., Kegelmeyer, D., Kloos, A., Rao, A. K., Busse, M., & Fritz, N. E. (2020). Clinical recommendations to guide physical therapy practice for Huntington disease. Neurology, 94(5), 217\u2013228. https:\/\/doi.org\/10.1212\/WNL.0000000000008887","journal-title":"Neurology"},{"issue":"1","key":"488_CR208","doi-asserted-by":"publisher","DOI":"10.1186\/s42466-023-00285-1","volume":"5","author":"C Saft","year":"2023","unstructured":"Saft, C., Burgunder, J.-M., Dose, M., Jung, H. H., Katzenschlager, R., Priller, J., Nguyen, H. P., Reetz, K., Reilmann, R., Seppi, K., & Landwehrmeyer, G. B. (2023). Symptomatic treatment options for Huntington\u2019s disease (guidelines of the German Neurological Society). Neurological Research and Practice, 5(1), Article 61. https:\/\/doi.org\/10.1186\/s42466-023-00285-1","journal-title":"Neurological Research and Practice"},{"key":"488_CR209","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00710","author":"A-C Bachoud-L\u00e9vi","year":"2019","unstructured":"Bachoud-L\u00e9vi, A.-C., Ferreira, J., Massart, R., Youssov, K., Rosser, A., Busse, M., Craufurd, D., Reilmann, R., De Michele, G., Rae, D., Squitieri, F., Seppi, K., Perrine, C., Scherer-Gagou, C., Audrey, O., Verny, C., & Burgunder, J.-M. (2019). International guidelines for the treatment of Huntington\u2019s disease. Frontiers in Neurology. https:\/\/doi.org\/10.3389\/fneur.2019.00710","journal-title":"Frontiers in Neurology"},{"issue":"1","key":"488_CR210","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2217\/nmt.11.86","volume":"2","author":"L Quinn","year":"2012","unstructured":"Quinn, L., & Busse, M. (2012). Physiotherapy clinical guidelines for Huntington\u2019s Disease. Neurodegenerative Disease Management, 2(1), 21\u201331. https:\/\/doi.org\/10.2217\/nmt.11.86","journal-title":"Neurodegenerative Disease Management"},{"issue":"2","key":"488_CR211","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.312","volume":"5","author":"TM Cruickshank","year":"2015","unstructured":"Cruickshank, T. M., Thompson, J. A., Dom\u00ednguez D, J. F., Reyes, A. P., Bynevelt, M., Georgiou-Karistianis, N., Barker, R. A., & Ziman, M. R. (2015). The effect of multidisciplinary rehabilitation on brain structure and cognition in Huntington\u2019s disease: An exploratory study. Brain and Behavior, 5(2), Article e00312. https:\/\/doi.org\/10.1002\/brb3.312","journal-title":"Brain and Behavior"},{"issue":"22","key":"488_CR212","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192214915","volume":"19","author":"M Al-Wardat","year":"2022","unstructured":"Al-Wardat, M., Schirinzi, T., Hadoush, H., Kassab, M., Yabroudi, M. A., Opara, J., Nawrat-Szo\u0142tysik, A., Khalil, H., & Etoom, M. (2022). Home-based exercise to improve motor functions, cognitive functions, and quality of life in people with Huntington\u2019s disease: A systematic review and meta-analysis. International Journal of Environmental Research and Public Health, 19(22), Article 14915. https:\/\/doi.org\/10.3390\/ijerph192214915","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"1","key":"488_CR213","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2217\/nmt.11.68","volume":"2","author":"G Manley","year":"2012","unstructured":"Manley, G., Lane, H., Carlsson, A., Ahlborg, B., M\u00e5rtensson, \u00c5., Nilsson, M. B., Simpson, S. A., & Rae, D. (2012). Guideline for oral healthcare of adults with Huntington\u2019s disease. Neurodegenerative Disease Management, 2(1), 55\u201365. https:\/\/doi.org\/10.2217\/nmt.11.68","journal-title":"Neurodegenerative Disease Management"},{"issue":"1","key":"488_CR214","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JHD-190384","volume":"9","author":"E Burnip","year":"2020","unstructured":"Burnip, E., Wallace, E., Gozdzikowska, K., & Huckabee, M. L. (2020). A systematic review of rehabilitation for corticobulbar symptoms in adults with Huntington\u2019s disease. Journal of Huntington\u2019s Disease, 9(1), 1\u201312. https:\/\/doi.org\/10.3233\/JHD-190384","journal-title":"Journal of Huntington's Disease"},{"issue":"1","key":"488_CR215","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2217\/nmt.11.69","volume":"2","author":"A Brotherton","year":"2012","unstructured":"Brotherton, A., Campos, L., Rowell, A., Zoia, V., Simpson, S. A., & Rae, D. (2012). Special report - Nutritional management of individuals with Huntington\u2019s disease: Nutritional guidelines. Neurodegenerative Disease Management, 2(1), 33\u201343. https:\/\/doi.org\/10.2217\/nmt.11.69","journal-title":"Neurodegenerative Disease Management"},{"issue":"7","key":"488_CR216","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/mds.27676","volume":"34","author":"L Vel\u00e1zquez-P\u00e9rez","year":"2019","unstructured":"Vel\u00e1zquez-P\u00e9rez, L., Rodr\u00edguez-Diaz, J. C., Rodr\u00edguez-Labrada, R., Medrano-Montero, J., Aguilera Cruz, A. B., Reynaldo-Cejas, L., G\u00f3ngora-Marrero, M., Estupi\u00f1\u00e1n-Rodr\u00edguez, A., V\u00e1zquez-Mojena, Y., & Torres-Vega, R. (2019). Neurorehabilitation improves the motor features in prodromal SCA2: A randomized, controlled trial. Movement Disorders: Official Journal of the Movement Disorder Society, 34(7), 1060\u20131068. https:\/\/doi.org\/10.1002\/mds.27676","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"3","key":"488_CR217","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/cge.14658","volume":"107","author":"S Biglari","year":"2025","unstructured":"Biglari, S., Nikuei, P., Mir, A., Vahidnezhad, H., Youssefian, L., Moghaddam, A. S., Tabatabaiefar, M. A., Saeidian, A. H., Khorram, E., Fard, M. A. F., Farbood, Z., Shahrooei, M., Khorshid, H. R. K., & Esmaeilzadeh, E. (2025). Ataxia with vitamin E deficiency: Case series, vitamin E therapy response, founder effect, and in silico analysis. Clinical Genetics, 107(3), 366\u2013368. https:\/\/doi.org\/10.1111\/cge.14658","journal-title":"Clinical Genetics"},{"key":"488_CR218","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1013-9","volume":"14","author":"R de Silva","year":"2019","unstructured":"de Silva, R., Greenfield, J., Cook, A., Bonney, H., Vallortigara, J., Hunt, B., & Giunti, P. (2019). Guidelines on the diagnosis and management of the progressive ataxias. Orphanet Journal of Rare Diseases, 14, Article 51. https:\/\/doi.org\/10.1186\/s13023-019-1013-9","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"7","key":"488_CR219","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1177\/1545968317712469","volume":"31","author":"SC Milne","year":"2017","unstructured":"Milne, S. C., Corben, L. A., Georgiou-Karistianis, N., Delatycki, M. B., & Yiu, E. M. (2017). Rehabilitation for individuals with genetic degenerative ataxia: A systematic review. Neurorehabilitation and Neural Repair, 31(7), 609\u2013622. https:\/\/doi.org\/10.1177\/1545968317712469","journal-title":"Neurorehabilitation and Neural Repair"},{"issue":"3","key":"488_CR220","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/ana.27130","volume":"97","author":"SC Milne","year":"2025","unstructured":"Milne, S. C., Roberts, M., Williams, S., Chua, J., Grootendorst, A. C., Agostinelli, G., Grobler, A. C., Ross, H. L., Robinson, A., Grove, K., Modderman, G., Price, A., Thomson, M., Massey, L., Liang, C., Kumar, K. R., Dalziel, K., Burns, J., Sue, C. M., & Delatycki, M. B. (2025). Goal-directed rehabilitation versus standard care for individuals with hereditary cerebellar ataxia: A multicenter, single-blind, randomized controlled superiority trial. Annals of Neurology, 97(3), 409\u2013424. https:\/\/doi.org\/10.1002\/ana.27130","journal-title":"Annals of Neurology"},{"key":"488_CR221","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1491142","volume":"15","author":"A Matsugi","year":"2025","unstructured":"Matsugi, A., Bando, K., Kondo, Y., Kikuchi, Y., Miyata, K., Hiramatsu, Y., Yamanaka, Y., Tanaka, H., Okuda, Y., Haruyama, K., & Yamasaki, Y. (2025). Effects of physiotherapy on degenerative cerebellar ataxia: A systematic review and meta-analysis. Frontiers in Neurology, 15, Article 1491142. https:\/\/doi.org\/10.3389\/fneur.2024.1491142","journal-title":"Frontiers in Neurology"},{"key":"488_CR222","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/583507","volume":"2014","author":"M Synofzik","year":"2014","unstructured":"Synofzik, M., & Ilg, W. (2014). Motor training in degenerative spinocerebellar disease: Ataxia-specific improvements by intensive physiotherapy and exergames. BioMed Research International, 2014, Article 583507. https:\/\/doi.org\/10.1155\/2014\/583507","journal-title":"BioMed Research International"},{"issue":"2","key":"488_CR223","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10072-015-2379-7","volume":"37","author":"T Tykalova","year":"2016","unstructured":"Tykalova, T., Pospisilova, M., Cmejla, R., Jerabek, J., Mares, P., & Rusz, J. (2016). Speech changes after coordinative training in patients with cerebellar ataxia: A pilot study. Neurological Sciences, 37(2), 293\u2013296. https:\/\/doi.org\/10.1007\/s10072-015-2379-7","journal-title":"Neurological Sciences"},{"issue":"8","key":"488_CR224","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1002\/acn3.51613","volume":"9","author":"AP Vogel","year":"2022","unstructured":"Vogel, A. P., Graf, L. H., Magee, M., Sch\u00f6ls, L., Rommel, N., & Synofzik, M. (2022). Home-based biofeedback speech treatment improves dysarthria in repeat-expansion SCAs. Annals of Clinical and Translational Neurology, 9(8), 1310\u20131315. https:\/\/doi.org\/10.1002\/acn3.51613","journal-title":"Annals of Clinical and Translational Neurology"},{"issue":"10","key":"488_CR225","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008953.pub2","volume":"2014","author":"AP Vogel","year":"2014","unstructured":"Vogel, A. P., Folker, J., & Poole, M. L. (2014). Treatment for speech disorder in Friedreich ataxia and other hereditary ataxia syndromes. Cochrane Database of Systematic Reviews, 2014(10), Article CD008953. https:\/\/doi.org\/10.1002\/14651858.CD008953.pub2","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"488_CR226","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1055\/s-0042-1755203","volume":"80","author":"G Diaf\u00e9ria","year":"2022","unstructured":"Diaf\u00e9ria, G., Bommarito, S., Braga Neto, P., Park, S. W., Padovani, M., Haddad, F., Haddad, L., Voos, M. C., Chien, H. F., Pedroso, J. L., & Barsottini, O. (2022). Effect of speech therapy on quality of life in patients with spinocerebelar ataxia type 3. Arquivos de Neuro-Psiquiatria, 80(10), 1017\u20131025. https:\/\/doi.org\/10.1055\/s-0042-1755203","journal-title":"Arquivos de Neuro-Psiquiatria"},{"issue":"12","key":"488_CR227","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1002\/mds.29199","volume":"37","author":"C La\u00dfmann","year":"2022","unstructured":"La\u00dfmann, C., Ilg, W., Schneider, M., V\u00f6lker, M., Haeufle, D. F. B., Sch\u00fcle, R., Giese, M., Synofzik, M., Sch\u00f6ls, L., & Rattay, T. W. (2022). Specific gait changes in prodromal hereditary spastic paraplegia type 4: PreSPG4 study. Movement Disorders, 37(12), 2417\u20132426. https:\/\/doi.org\/10.1002\/mds.29199","journal-title":"Movement Disorders"},{"issue":"3","key":"488_CR228","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1093\/brain\/awac155","volume":"146","author":"TW Rattay","year":"2023","unstructured":"Rattay, T. W., V\u00f6lker, M., Rautenberg, M., Kessler, C., Wurster, I., Winter, N., Haack, T. B., Lindig, T., Hengel, H., Synofzik, M., Sch\u00fcle, R., Martus, P., & Sch\u00f6ls, L. (2023). The prodromal phase of hereditary spastic paraplegia type 4: The preSPG4 cohort study. Brain, 146(3), 1093\u20131102. https:\/\/doi.org\/10.1093\/brain\/awac155","journal-title":"Brain"},{"key":"488_CR229","doi-asserted-by":"publisher","unstructured":"Faccioli, S., Cavalagli, A., Falocci, N., Mangano, G., Sanfilippo, I., & Sassi, S. (2023). Gait analysis patterns and rehabilitative interventions to improve gait in persons with hereditary spastic paraplegia: A systematic review and meta-analysis. Frontiers in Neurology, 14. https:\/\/doi.org\/10.3389\/fneur.2023.1256392","DOI":"10.3389\/fneur.2023.1256392"},{"key":"488_CR230","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1292527","volume":"14","author":"A Di Ludovico","year":"2023","unstructured":"Di Ludovico, A., Ciarelli, F., La Bella, S., Scorrano, G., Chiarelli, F., & Farello, G. (2023). The therapeutic effects of physical treatment for patients with hereditary spastic paraplegia: A narrative review. Frontiers in Neurology, 14, Article 1292527. https:\/\/doi.org\/10.3389\/fneur.2023.1292527","journal-title":"Frontiers in Neurology"},{"issue":"4","key":"488_CR231","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.gaitpost.2014.01.010","volume":"39","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y., Roxburgh, R., Huang, L., Parsons, J., & Davies, T. C. (2014). The effect of hydrotherapy treatment on gait characteristics of hereditary spastic paraparesis patients. Gait & Posture, 39(4), 1074\u20131079. https:\/\/doi.org\/10.1016\/j.gaitpost.2014.01.010","journal-title":"Gait & Posture"},{"key":"488_CR232","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ejpn.2024.03.003","volume":"49","author":"L Laugwitz","year":"2024","unstructured":"Laugwitz, L., Schoenmakers, D. H., Adang, L. A., Beck-Woedl, S., Bergner, C., Bernard, G., Bley, A., Boyer, A., Calbi, V., Dekker, H., Eichler, F., Eklund, E., Fumagalli, F., Gavazzi, F., Gr\u00f8nborg, S. W., van Hasselt, P., Langeveld, M., Lindemans, C., Mochel, F., \u2026 Groeschel, S. (2024). Newborn screening in metachromatic leukodystrophy\u2014European consensus-based recommendations on clinical management. European Journal of Paediatric Neurology, 49, 141\u2013154. https:\/\/doi.org\/10.1016\/j.ejpn.2024.03.003","journal-title":"European Journal of Paediatric Neurology"},{"issue":"5","key":"488_CR233","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.braindev.2017.01.001","volume":"39","author":"MR Ashrafi","year":"2017","unstructured":"Ashrafi, M. R., & Tavasoli, A. R. (2017). Childhood leukodystrophies: A literature review of updates on new definitions, classification, diagnostic approach and management. Brain and Development, 39(5), 369\u2013385. https:\/\/doi.org\/10.1016\/j.braindev.2017.01.001","journal-title":"Brain and Development"},{"issue":"1","key":"488_CR234","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ymgme.2017.08.006","volume":"122","author":"LA Adang","year":"2017","unstructured":"Adang, L. A., Sherbini, O., Ball, L., Bloom, M., Darbari, A., Amartino, H., DiVito, D., Eichler, F., Escolar, M., Evans, S. H., Fatemi, A., Fraser, J., Hollowell, L., Jaffe, N., Joseph, C., Karpinski, M., Keller, S., Maddock, R., Mancilla, E., \u2026 Vanderver, A. (2017). Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies. Molecular Genetics and Metabolism, 122(1), 18\u201332. https:\/\/doi.org\/10.1016\/j.ymgme.2017.08.006","journal-title":"Molecular Genetics and Metabolism"},{"issue":"9","key":"488_CR235","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/mdc3.70136","volume":"12","author":"E Ortega-Robles","year":"2025","unstructured":"Ortega-Robles, E., Shalash, A., Ram\u00edrez-Berm\u00fadez, J., & Arias-Carri\u00f3n, O. (2025). Functional Movement Disorder: Evolving mechanisms, diagnostic precision, and personalized multidisciplinary care. Movement Disorders Clinical Practice, 12(9), 1244\u20131258. https:\/\/doi.org\/10.1002\/mdc3.70136","journal-title":"Movement Disorders Clinical Practice"},{"issue":"10","key":"488_CR236","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1136\/jnnp-2024-334788","volume":"96","author":"G Ostuzzi","year":"2025","unstructured":"Ostuzzi, G., Geroin, C., Gastaldon, C., Tedeschi, F., Clesi, F. M., Trevisan, G., Bidello, G., Vita, G., Marcuzzo, E., Sandri, A., Romito, L. M., Eleopra, R., Tesolin, L., Franch, I., Zappia, M., Nicoletti, A., Demartini, B., Nistic\u00f2, V., Modugno, N., \u2026 Tinazzi, M. (2025). Characterising alexithymia in individuals with functional motor disorders: A cross-sectional analysis of the Italian Registry of Functional Motor Disorders. Journal of Neurology, Neurosurgery, and Psychiatry, 96(10), 990\u2013997. https:\/\/doi.org\/10.1136\/jnnp-2024-334788","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"6","key":"488_CR237","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1590\/0004-282x20200009","volume":"78","author":"RV Theuer","year":"2020","unstructured":"Theuer, R. V., Neves, S. V. N., & Champs, A. P. S. (2020). Rehabilitation for motor functional neurological disorder: A follow-up study of 185 patients. Arquivos de Neuro-Psiquiatria, 78(6), 331\u2013336. https:\/\/doi.org\/10.1590\/0004-282x20200009","journal-title":"Arquivos de Neuro-Psiquiatria"},{"issue":"6","key":"488_CR238","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1080\/09638288.2024.2373775","volume":"47","author":"H Bhatt","year":"2025","unstructured":"Bhatt, H., MacGillivray, L., Gilmour, G. S., Marcelle, K., Langer, L., & Lidstone, S. C. (2025). Integrated model of care for functional movement disorder: Targeting brain, mind and body. Disability and Rehabilitation, 47(6), 1433\u20131441. https:\/\/doi.org\/10.1080\/09638288.2024.2373775","journal-title":"Disability and Rehabilitation"},{"issue":"2","key":"488_CR239","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ncl.2020.01.011","volume":"38","author":"K LaFaver","year":"2020","unstructured":"LaFaver, K. (2020). Treatment of functional movement disorders. Neurologic Clinics, 38(2), 469\u2013480. https:\/\/doi.org\/10.1016\/j.ncl.2020.01.011","journal-title":"Neurologic Clinics"},{"issue":"7","key":"488_CR240","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S1474-4422(24)00135-2","volume":"23","author":"G Nielsen","year":"2024","unstructured":"Nielsen, G., Stone, J., Lee, T. C., Goldstein, L. H., Marston, L., Hunter, R. M., Carson, A., Holt, K., Marsden, J., Le Novere, M., Nazareth, I., Noble, H., Reuber, M., Strudwick, A.-M., Santana Suarez, B., Edwards, M. J., Physio4FMD study group. (2024). Specialist physiotherapy for functional motor disorder in England and Scotland (Physio4FMD): A pragmatic, multicentre, phase 3 randomised controlled trial. The Lancet. Neurology, 23(7), 675\u2013686. https:\/\/doi.org\/10.1016\/S1474-4422(24)00135-2","journal-title":"The Lancet. Neurology"},{"issue":"14","key":"488_CR241","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1080\/09638288.2019.1691666","volume":"43","author":"K Shrubsole","year":"2021","unstructured":"Shrubsole, K. (2021). Implementation of an integrated multidisciplinary Movement Disorders Clinic: Applying a knowledge translation framework to improve multidisciplinary care. Disability and Rehabilitation, 43(14), 2071\u20132083. https:\/\/doi.org\/10.1080\/09638288.2019.1691666","journal-title":"Disability and Rehabilitation"},{"key":"488_CR242","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.parkreldis.2020.11.018","volume":"82","author":"C Hebert","year":"2021","unstructured":"Hebert, C., Behel, J. M., Pal, G., Kasi, R., & Kompoliti, K. (2021). Multidisciplinary inpatient rehabilitation for functional movement disorders: A prospective study with long term follow up. Parkinsonism & Related Disorders, 82, 50\u201355. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.11.018","journal-title":"Parkinsonism & Related Disorders"},{"issue":"2","key":"488_CR243","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mdc3.12888","volume":"7","author":"SC Lidstone","year":"2020","unstructured":"Lidstone, S. C., MacGillivray, L., & Lang, A. E. (2020). Integrated therapy for functional movement disorders: Time for a change. Movement Disorders Clinical Practice, 7(2), 169\u2013174. https:\/\/doi.org\/10.1002\/mdc3.12888","journal-title":"Movement Disorders Clinical Practice"},{"issue":"11","key":"488_CR244","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.pmrj.2018.05.011","volume":"10","author":"AE Jacob","year":"2018","unstructured":"Jacob, A. E., Kaelin, D. L., Roach, A. R., Ziegler, C. H., & LaFaver, K. (2018). Motor retraining (MoRe) for functional movement disorders: Outcomes from a 1-week multidisciplinary rehabilitation program. PM & R\u202f: The Journal of Injury, Function, and Rehabilitation, 10(11), 1164\u20131172. https:\/\/doi.org\/10.1016\/j.pmrj.2018.05.011","journal-title":"PM & R : The Journal of Injury, Function, and Rehabilitation"},{"issue":"19","key":"488_CR245","doi-asserted-by":"publisher","first-page":"e1787","DOI":"10.1212\/WNL.0000000000008442","volume":"93","author":"AJ Espay","year":"2019","unstructured":"Espay, A. J., Ries, S., Maloney, T., Vannest, J., Neefus, E., Dwivedi, A. K., Allendorfer, J. B., Wulsin, L. R., LaFrance, W. C., Lang, A. E., & Szaflarski, J. P. (2019). Clinical and neural responses to cognitive behavioral therapy for functional tremor. Neurology, 93(19), e1787\u2013e1798. https:\/\/doi.org\/10.1212\/WNL.0000000000008442","journal-title":"Neurology"},{"issue":"2","key":"488_CR246","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000049348","volume":"71","author":"FC Moene","year":"2002","unstructured":"Moene, F. C., Spinhoven, P., Hoogduin, K. A. L., & van Dyck, R. (2002). A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychotherapy and Psychosomatics, 71(2), 66\u201376. https:\/\/doi.org\/10.1159\/000049348","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"1","key":"488_CR247","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1076\/iceh.51.1.29.14067","volume":"51","author":"FC Moene","year":"2003","unstructured":"Moene, F. C., Spinhoven, P., Hoogduin, K. A. L., & van Dyck, R. (2003). A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. The International Journal of Clinical and Experimental Hypnosis, 51(1), 29\u201350. https:\/\/doi.org\/10.1076\/iceh.51.1.29.14067","journal-title":"The International Journal of Clinical and Experimental Hypnosis"},{"issue":"10","key":"488_CR248","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1136\/jnnp-2014-309255","volume":"86","author":"G Nielsen","year":"2015","unstructured":"Nielsen, G., Stone, J., Matthews, A., Brown, M., Sparkes, C., Farmer, R., Masterton, L., Duncan, L., Winters, A., Daniell, L., Lumsden, C., Carson, A., David, A. S., & Edwards, M. (2015). Physiotherapy for functional motor disorders: A consensus recommendation. Journal of Neurology, Neurosurgery, and Psychiatry, 86(10), 1113\u20131119. https:\/\/doi.org\/10.1136\/jnnp-2014-309255","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"2","key":"488_CR249","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jpsychores.2013.10.003","volume":"76","author":"J Stone","year":"2014","unstructured":"Stone, J., Hoeritzauer, I., Brown, K., & Carson, A. (2014). Therapeutic sedation for functional (psychogenic) neurological symptoms. Journal of Psychosomatic Research, 76(2), 165\u2013168. https:\/\/doi.org\/10.1016\/j.jpsychores.2013.10.003","journal-title":"Journal of Psychosomatic Research"},{"issue":"6","key":"488_CR250","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.nrleng.2022.01.008","volume":"39","author":"P Molero-Mateo","year":"2024","unstructured":"Molero-Mateo, P., & Molina-Rueda, F. (2024). Physiotherapy for patients with functional movement disorder: A systematic review. Neurolog\u00eda (Barcelona, Spain), 39(6), 505\u2013514. https:\/\/doi.org\/10.1016\/j.nrleng.2022.01.008","journal-title":"Neurolog\u00eda (Barcelona, Spain)"},{"issue":"9","key":"488_CR251","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1001\/jamaneurol.2024.2393","volume":"81","author":"D Mac\u00edas-Garc\u00eda","year":"2024","unstructured":"Mac\u00edas-Garc\u00eda, D., M\u00e9ndez-Del Barrio, M., Canal-Rivero, M., Mu\u00f1oz-Delgado, L., Adarmes-G\u00f3mez, A., Jes\u00fas, S., Ojeda-Lepe, E., Carrillo-Garc\u00eda, F., Palomar, F. J., G\u00f3mez-Campos, F. J., Martin-Rodriguez, J. F., Crespo-Facorro, B., Ruiz-Veguilla, M., & Mir, P. (2024). Combined physiotherapy and cognitive behavioral therapy for functional movement disorders: A randomized clinical trial. JAMA Neurology, 81(9), 966\u2013976. https:\/\/doi.org\/10.1001\/jamaneurol.2024.2393","journal-title":"JAMA Neurology"},{"issue":"11","key":"488_CR252","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.pmrj.2018.05.011","volume":"10","author":"AE Jacob","year":"2018","unstructured":"Jacob, A. E., Kaelin, D. L., Roach, A. R., Ziegler, C. H., & LaFaver, K. (2018). Motor retraining (MoRe) for functional movement disorders: Outcomes from a 1-week multidisciplinary rehabilitation program. PM & R\u202f: The Journal of Injury, Function, and Rehabilitation, 10(11), 1164\u20131172. https:\/\/doi.org\/10.1016\/j.pmrj.2018.05.011","journal-title":"PM & R : The Journal of Injury, Function, and Rehabilitation"}],"container-title":["Neurological Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-026-00488-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42466-026-00488-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-026-00488-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:23:11Z","timestamp":1776698591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42466-026-00488-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":252,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["488"],"URL":"https:\/\/doi.org\/10.1186\/s42466-026-00488-2","relation":{},"ISSN":["2524-3489"],"issn-type":[{"value":"2524-3489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"10 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}